topic0
Estrogen [horm, phsu, strd] 0.0046529417864
Oral [spco] 0.00379515769717
Men [popg] 0.00369582783869
N NOS [aapp, imft] 0.00362097319094
placebo [topp] 0.00348326831463
mg% [qnco] 0.00279110392678
Blood Pressure [orgf] 0.0025702000629
Menopause [phsf] 0.00253063832407
Combined [qlco] 0.00251295779225
Myocardial Infarction [dsyn] 0.00232863738717
Atherosclerosis [dsyn] 0.00217838339782
Raloxifene [orch, phsu] 0.00213498022473
Decrease [qlco] 0.00207812309924
Plasma [bdsu] 0.00205222323273
randomized [resa] 0.00200047189997
Similar [qlco] 0.00196468810284
Incidence [qnco] 0.00192664015682
Subject [grup] 0.00189251905066
Drugs [phsu] 0.00187841551319
Decreased [qnco] 0.00187663864502
Breast Cancer [neop] 0.00186837772349
Measured [qlco] 0.00185954407328
Profile [lbpr] 0.00183846761046
Estradiol [horm, phsu, strd] 0.00179972925851
High Density Lipoprotein Cholesterol [bacs, lipd] 0.00174130060454
Osteoporosis [dsyn] 0.00173777046256
Early [tmco] 0.00171852607404
coronary [bpoc] 0.00171847835569
Association [menp] 0.00171482822261
Induced [ftcn] 0.00170678450499
Serum [bdsu] 0.00169428829545
Change [ftcn] 0.0016898979397
Stroke [dsyn] 0.00168160015128
C-reactive protein [aapp, imft] 0.00165102154436
Benefit [qnco] 0.00164821459593
Old [tmco] 0.0015891880361
Statins [orch, phsu] 0.00158551563548
Events [evnt] 0.00157894185572
Drug Therapy [topp] 0.00156266053047
Received [qlco] 0.00155266074045
coronary artery disease [dsyn] 0.00154896671007
Diabetes [dsyn] 0.00153876504601
Non [ftcn] 0.00151755692256
Cholesterol [bacs, strd] 0.00149076643824
Lipid [lipd] 0.00147828138182
Equal [qlco] 0.00147156082637
Science [ocdi] 0.00145315787943
diabetic [fndg] 0.00143997075799
Progestin [horm, phsu, strd] 0.00143627759361
Common [qnco] 0.00141640110957
mmHg [qnco] 0.00139906013836
function [phsf] 0.00138928654936
High Risk [qlco] 0.00138901931388
weeks [tmco] 0.00138892531306
Total Cholesterol [lbpr] 0.00138152176939
PREVENT [phsu] 0.00136987503778
Receive [qlco] 0.00136789673038
Cases [ftcn] 0.00136745310189
Body Mass Index [diap] 0.00135565198078
Take [hlca] 0.00130998616136
Current [tmco] 0.00130898384183
Equine [mamm] 0.00129864655007
mg dl [qnco] 0.00129807855314
Large [qnco] 0.00128191150009
Diet [food] 0.00128060418232
Acute myocardial infarction [dsyn] 0.00127902359443
Care [acty] 0.0012782600488
Aspirin [orch, phsu] 0.00127657656036
Estrogens [horm, phsu, strd] 0.00126021907054
Heart disease [dsyn] 0.00125292571495
Confidence Interval [qnco] 0.00125097238824
Concentrations [menp] 0.00123987590217
Several [qnco] 0.0012379971428
Marker [clna] 0.00123595273185
Reported [inpr] 0.00122772254973
Administration [ocac] 0.00122641584005
Recent [tmco] 0.00122511525839
Evaluated [ftcn] 0.00122480985529
Benefits [qnco] 0.00122406474258
development [phsf] 0.00122290548773
Range [qnco] 0.00122255539778
Independent [idcn] 0.00121569192461
days [tmco] 0.00121492988108
Dose [qnco] 0.00121142506486
intervention [hlca] 0.001210148043
Death [orgf] 0.00120457264239
cardiovascular risk factor [dsyn] 0.00118210450404
R- [spco] 0.00117998701418
lowering [spco] 0.00117390722336
Available [ftcn] 0.00117052082611
Increasing [ftcn] 0.00115644449631
Improvement [cnce] 0.00115154112483
Plus [qlco] 0.00113524639522
Users [humn] 0.00113031067553
Overall [inpr] 0.0011289652595
Values [qlco] 0.00112597174551
low [qlco] 0.00112572686865
considered [idcn] 0.00112316718569
Often [tmco] 0.0011168975683
Prevalence [qnco] 0.00111447559416
mg day [qnco] 0.00111219498869
ischaemic heart disease [dsyn] 0.00110393668571
Cholesterol, LDL [bacs, strd] 0.00110149486774
hypertensive [fndg] 0.00109483274122
Drug [phsu] 0.00108698295493
symptoms [ftcn] 0.00107685701523
LTD [ortf] 0.00107471594554
APPEAR [qlco] 0.00107338239545
medroxyprogesterone acetate [horm, phsu, strd] 0.00107302524417
HRT [topp] 0.00107267521901
Individual [popg] 0.00105541642672
Assessed [acty] 0.00104876591728
Four [qnco] 0.00104753936104
Surgery [bmod] 0.00104593584517
Possible [qlco] 0.00103817398845
Low Density Lipoprotein Cholesterol [bacs, strd] 0.00103483956532
Smoking [inbe] 0.00103452245677
Provide [acty] 0.00101791764928
Comparison [acty] 0.00101525427828
GIVEN [cnce] 0.00101333228248
Assess [acty] 0.00101011767911
Well [qlco] 0.00100799494756
Odds Ratio [qnco] 0.00100740742189
Guidelines [inpr] 0.00100544517116
Duration [tmco] 0.00100428711191
Cost Effectiveness [qnco] 0.00100003708004
Therapeutic [topp] 0.000993214879854
Diabetes Mellitus [dsyn] 0.000990755791128
setting [ftcn] 0.000989767154655
mediated [socb] 0.000989430856376
Status [qlco] 0.000982223784511
Affect [menp] 0.000979850894875
Various [irda] 0.000975061501024
Heart [bpoc] 0.000974962078231
Alone [qnco] 0.000969763949032
Relative Risk [qnco] 0.000967826643742
Tamoxifen [orch, phsu] 0.00096441774581
Conjugated estrogen [horm, phsu, strd] 0.000959761478063
Cohort [popg] 0.000953390833079
findings [ftcn] 0.000953185810806
Null [qnco] 0.000949075178212
Approach [spco] 0.000947599022608
Medical [ftcn] 0.000946815748418
IMPACT [gngm] 0.000943882273708
radiotherapy [inpr] 0.000942954429841
condition [dsyn] 0.000938505196359
Part [spco] 0.000938353769593
Aged [orga] 0.000932946560088
measurements [ftcn] 0.000931490254958
Primary [qlco] 0.000929082551474
Life [idcn] 0.000928511638404
Continuous [idcn] 0.000926821481321
regimens [inpr] 0.00092497098115
experience [menp] 0.000919683198746
Hospital [hcro, mnob] 0.000919368475502
Cardiac [bpoc] 0.000916612506236
Clinical Trials [resa] 0.000916472794822
Daily [tmco] 0.000915969336946
In [qnco] 0.000908217959102
Following [tmco] 0.000906677451044
Improved [qlco] 0.000900105720684
Quality [qlco] 0.000896667857888
Make [ftcn] 0.000890731396654
Index [inpr] 0.000889807505731
Known [qlco] 0.000888836206449
Presence [topp] 0.000883586196861
Published [ocac] 0.000882427852176
Specific [qlco] 0.000879496012884
Percent [qnco] 0.000876272611284
Main [qlco] 0.000874836457822
Hypercholesterolaemia [dsyn] 0.0008718088954
Examined [fndg] 0.000870462922697
Endothelial [tisu] 0.000868605209278
Insulin [aapp, horm, phsu] 0.00086827972457
activity [dora] 0.000866352181974
Past [tmco] 0.000866171930618
Systolic [tmco] 0.000862901074681
Recommended [idcn] 0.000862460812149
median [spco] 0.000861878465118
practice [menp] 0.000856812976304
progression [patf] 0.00085592663705
Reducing [qlco] 0.000853032372894
Combination [qlco] 0.000847522541469
Physicians [prog] 0.000847475743815
Single [popg] 0.000846941894692
acute [tmco] 0.000845022338541
tibolone [phsu, strd] 0.000834350328009
I- [inch] 0.00083248066727
Compare [acty] 0.000832127282474
Predictor [idcn] 0.000827698341291
Triglycerides [bacs, lipd] 0.00082337235876
Average [qnco] 0.000819847104398
Secondary Prevention [topp] 0.000814721128382
participants [popg] 0.00081113996795
Elderly [popg] 0.000807931507464
Safety [hcpp] 0.000807603410131
Seen [qlco] 0.000806613619829
Strong [qlco] 0.000806129400058
Exercise [dora] 0.000805064556398
Established [qlco] 0.000804144838322
month [tmco] 0.000802378009114
Response [orga] 0.000802287584504
Support [medd] 0.000800715886643
prospective [resa] 0.000799575048912
Cancer [neop] 0.000797869852078
Obtained [ftcn] 0.000797247894428
Agent [chvf] 0.000794282796155
vascular [bpoc] 0.000790038054203
Dependent [qlco] 0.000788820540907
Transdermal [ftcn] 0.000787743221883
Conduct [inbe] 0.000786334102834
Flow [npop] 0.000785384477185
Hormone [horm] 0.000785296951237
cardiovascular events [fndg] 0.000783434748556
Need [qlco] 0.000783379077956
influential [idcn] 0.000781053238259
Severe [qlco] 0.000781003324714
variables [qlco] 0.000780486436903
Information [idcn] 0.000779263985122
Parameters [fndg] 0.000774714102132
Addition [ftcn] 0.000774681092883
Ireland [geoa] 0.000768301796522
Required [ftcn] 0.000766522469084
Sclerotherapy [topp] 0.000766098661784
Diagnosis [fndg] 0.000765929618711
Five [qnco] 0.000759841294509
Future [tmco] 0.000757351889536
Survival [acty] 0.00075684331594
premenopausal [tmco] 0.000756752673072
Interaction [ftcn] 0.000754386842541
Purpose [ftcn] 0.000752629164839
Coronary heart disease risk [inpr] 0.000751140484759
Identified [qlco] 0.000750740731919
Echocardiography [diap] 0.000748194478998
Multiple [qnco] 0.00074042420123
Same [qlco] 0.000739834788084
Likely [qlco] 0.000739646250719
objectives [inpr] 0.000737583763378
Defined [cnce] 0.000735389949258
Life Style [socb] 0.000734032892575
Adjusted [ftcn] 0.000731986132897
H+ [elii] 0.000728188465216
Mechanisms [ftcn] 0.000725543387439
DOUBLE BLIND [resa] 0.000724312835725
Damage [inpo] 0.00072312982598
Correlation [qlco] 0.000715046102223
Intima media thickness [clna] 0.000710268985947
Velocity [qnco] 0.00070874612814
Estrogen Replacement Therapy [topp] 0.00070820816243
Elevated [qlco] 0.000706672110601
Concern [idcn] 0.000706053243532
Obesity [dsyn] 0.000701887287402
Target [ftcn] 0.000701615805353
Help [socb] 0.000699841709033
Lipoprotein [aapp, bacs] 0.00069924099741
Altered [ftcn] 0.000698922095443
Relationship [qlco] 0.000698864994473
Arterial [bpoc] 0.000698652553453
Fibrinogen [aapp, bacs, phsu] 0.000697180235697
Risks [qlco] 0.000696518960356
Initial [tmco] 0.000694119619493
Statin [orch, phsu] 0.000686979272351
Low density lipoprotein [aapp, bacs, lipd] 0.000685925289942
Long [qlco] 0.000685284531913
Occur [acty] 0.000681957877398
Measure [qnco] 0.000681675315414
Lipoproteins [aapp, bacs] 0.000678218259959
Six [qnco] 0.000676935956749
national [inpr] 0.000676838258646
Glucose [bacs, carb, phsu] 0.000672338140755
Dyslipidaemia [dsyn] 0.000669024710927
Assessment [hlca] 0.000667977089842
investigated [ftcn] 0.000667523598458
Morbidity [qnco] 0.000665799854115
Heart failure [dsyn] 0.000664005260274
homocysteine [aapp, bacs] 0.000663949676128
High density lipoprotein [aapp, bacs, lipd] 0.000662123600882
peripheral arterial disease [dsyn] 0.000661859009609
Primary Prevention [topp] 0.000661617675475
Diseases [dsyn] 0.000660425217367
Play [dora] 0.000655781954049
Progestagen [horm, phsu, strd] 0.000654799749637
Sex [orgf] 0.000650407949672
Evaluation [ftcn] 0.000650315486737
Select [acty] 0.00064591969562
Complex [qlco] 0.000645775067577
Doses [qnco] 0.000643488295658
Ratio [qnco] 0.000643080175249
Report [inpr] 0.000642990231553
Alternative [cnce] 0.000640662087226
Additional [ftcn] 0.000640484791822
Question [inpr] 0.000640098766869
American [popg] 0.000639669288518
matched [resa] 0.000639401255071
choice [inbe] 0.000638235057937
Conjugated Equine Estrogens [horm, phsu, strd] 0.000636895280778
Young [tmco] 0.000636326319521
Indicated [fndg] 0.00063517141726
Risk factor [qnco] 0.000633637220216
System [ftcn] 0.000633086204035
Very [qlco] 0.000632777409138
Contribute [acty] 0.000630057254516
Myocardial [spco] 0.00062658124826
Radiation [npop] 0.000626466709791
Model [inpr] 0.000626109507726
Favorable [qlco] 0.000624744404104
Diagnosed [fndg] 0.000624504220951
side effects [ftcn] 0.000623110171553
Article [inpr] 0.000616149052448
Estrogen Replacement [topp] 0.000612894202045
Value [qnco] 0.000612713816176
Relative [famg] 0.000611825490196
Direct [qlco] 0.000609488719049
Assigned [ftcn] 0.000606579496941
Third [qnco] 0.000603251643465
Estimated [qnco] 0.000602967829793
frequency [qnco] 0.000602290828711
History [ocdi] 0.000599153454356
Systolic blood pressure [clna] 0.000596311864704
Atrial Fibrillation [patf] 0.00059564812051
Administered [ftcn] 0.000586020535266
Recently [tmco] 0.000585611636943
Complications [patf] 0.000585451165158
Normal [qlco] 0.000583865108489
Occurred [acty] 0.000583543032793
mg/d [qnco] 0.000581666209905
placebo-controlled [resa] 0.000579705401682
Ii [aapp] 0.000576324838763
Lp(a) [aapp, bacs] 0.000575367094046
Dietary [food] 0.000575318475166
reductions [npop] 0.000575111061785
Pravastatin [orch, phsu] 0.000574000220861
Blood [tisu] 0.000570826981581
If [qlco] 0.000568580335191
Replacement [topp] 0.000567692754441
Lipoprotein (a) [aapp, bacs] 0.000563648973133
Controlled [ftcn] 0.000563214458155
Currently [tmco] 0.000562779971906
adverse effects [ftcn] 0.000561489149406
Screening [hlca] 0.000559644302307
Exposure NOS [inpo] 0.000559368283339
Area [geoa] 0.000558997852669
Prognostic Factor [clna] 0.000558256899068
Standard [qlco] 0.000557696764944
Needed [qlco] 0.000554585222576
Late [tmco] 0.000553128193956
Characteristics [qlco] 0.00055272953244
Few [qnco] 0.0005509371687
Normotensive [fndg] 0.000549758438619
End [spco] 0.000548773795946
Woman [popg] 0.000547372624591
Cost [qnco] 0.00054736574296
Limited [ftcn] 0.000547345878548
Human [humn] 0.000546612192366
menopausal symptoms [sosy] 0.000542917481325
investigate [ftcn] 0.000542733814855
Fasting [fndg] 0.000540952713432
Involved [ftcn] 0.000540901844038
Children [aggp] 0.000540786452401
Beta-Blockers [phsu] 0.000540401180898
Calcium [bacs, elii, phsu] 0.000540013110075
Post-Menopause [orgf] 0.000539978051775
Measures [qnco] 0.000539765399855
Initiate [idcn] 0.000538855179576
Literature [inpr] 0.00053803816965
atherosclerotic [ftcn] 0.000534515935473
Male [fndg] 0.000533218201453
Certain [qlco] 0.000531773271717
Address [inpr] 0.000528957694904
hormone replacement [topp] 0.000528528548587
reviewed [inpr] 0.000528028309031
mmol/L [qnco] 0.00052624104694
Cl - [elii] 0.00052608553221
Associations [menp] 0.000523951984513
Sample [sbst] 0.000523610987772
Inflammation [patf] 0.000521900804425
Onset [qlco] 0.000521034346192
Simvastatin [orch, phsu] 0.000520392197595
Appropriate [qlco] 0.000520278462249
interventions [hlca] 0.000518421940676
Understanding [menp] 0.000518398940784
Previous [tmco] 0.000516984981419
Control Group [grup] 0.000516405672507
Out [spco] 0.00051562566642
Better [qlco] 0.000514693276761
Systemic [ftcn] 0.000512058853298
Coronary Disease [dsyn] 0.000511879954279
Progesterone [horm, phsu, strd] 0.000511789612715
weight [orga] 0.000509573648473
Severity [qlco] 0.000508656925062
Sequential [idcn] 0.000507949285158
Issue [fndg] 0.000506940141743
Measurement [ftcn] 0.000506719317242
Class [inpr] 0.000504487698746
Medication [phsu] 0.000504174362745
TREAT [ftcn] 0.000502115449515
Case [ftcn] 0.000501437478449
Pacing [inbe] 0.000500729429332
Correlated [qlco] 0.000499697886087
Vascular Malformations [anab] 0.000499441245026
topic1
Estrogen [horm, phsu, strd] 0.00567402322945
N NOS [aapp, imft] 0.00526519611552
Menopause [phsf] 0.0028034393697
Plasma [bdsu] 0.00256290208565
placebo [topp] 0.00236709879499
mg% [qnco] 0.00234767485658
Lipid [lipd] 0.00231101344509
Subject [grup] 0.0022658587514
Old [tmco] 0.00224405786187
Combined [qlco] 0.0022293289578
Men [popg] 0.00217516367296
Received [qlco] 0.00214633333454
Incidence [qnco] 0.00208232137034
Atherosclerosis [dsyn] 0.00207145496996
Change [ftcn] 0.00202199939969
Benefit [qnco] 0.00197802892661
Receive [qlco] 0.00196229442275
Decrease [qlco] 0.00195269764434
Association [menp] 0.00193581403114
Acute myocardial infarction [dsyn] 0.0018788609458
Blood Pressure [orgf] 0.00187179727882
Decreased [qnco] 0.00182376360172
Oral [spco] 0.00178878536059
Cases [ftcn] 0.00175383866635
Drug Therapy [topp] 0.00175332428107
Aged [orga] 0.00174841068444
Estradiol [horm, phsu, strd] 0.00174229245192
Drug [phsu] 0.00173136657196
Current [tmco] 0.00172292913211
Users [humn] 0.00171890951492
Profile [lbpr] 0.0017044795444
Diabetes [dsyn] 0.00170172389611
mmHg [qnco] 0.00169657877127
Myocardial Infarction [dsyn] 0.00169003825652
randomized [resa] 0.00167365885008
Osteoporosis [dsyn] 0.00167197856517
C-reactive protein [aapp, imft] 0.00165163524647
Range [qnco] 0.00164279099804
Early [tmco] 0.00162552769374
Statins [orch, phsu] 0.00156663791494
Death [orgf] 0.00155658362367
coronary artery disease [dsyn] 0.00154821447367
Breast Cancer [neop] 0.00153967735837
Alone [qnco] 0.00151725347935
Events [evnt] 0.00150125716371
Measured [qlco] 0.00150054408368
Diet [food] 0.00149678934867
Improved [qlco] 0.00149264880713
Drugs [phsu] 0.00148807101317
mg dl [qnco] 0.00147691776825
Recent [tmco] 0.00146826512486
Science [ocdi] 0.00146327683565
Non [ftcn] 0.00146077273504
Raloxifene [orch, phsu] 0.00145873329414
Similar [qlco] 0.00145212585581
Several [qnco] 0.00145180738736
Progestin [horm, phsu, strd] 0.00144114475855
coronary [bpoc] 0.00142078598278
Values [qlco] 0.00141589716901
Confidence Interval [qnco] 0.00139895071131
Concentrations [menp] 0.00138816312767
LTD [ortf] 0.00138160121061
considered [idcn] 0.00137291323678
Cholesterol [bacs, strd] 0.00133651138411
Improvement [cnce] 0.00133076055906
Aspirin [orch, phsu] 0.00132453737826
Equal [qlco] 0.00130061737994
medroxyprogesterone acetate [horm, phsu, strd] 0.00129577671183
Assessed [acty] 0.00128838635355
Dose [qnco] 0.00127902436717
Elderly [popg] 0.00127448525886
Take [hlca] 0.00126569431953
High Density Lipoprotein Cholesterol [bacs, lipd] 0.00125297730004
Assess [acty] 0.00124879086542
Medical [ftcn] 0.00124810140486
Stroke [dsyn] 0.00124361599945
Total Cholesterol [lbpr] 0.00124078787207
lowering [spco] 0.0012269712777
Specific [qlco] 0.00122178174227
Evaluated [ftcn] 0.00119603712138
Marker [clna] 0.00119032907901
weeks [tmco] 0.00118097023723
Benefits [qnco] 0.00117563748274
Conjugated estrogen [horm, phsu, strd] 0.00117310578486
Prevalence [qnco] 0.00117046102269
Established [qlco] 0.00116837373033
Parameters [fndg] 0.00116655182152
Induced [ftcn] 0.00116483109206
Body Mass Index [diap] 0.00116395630614
intervention [hlca] 0.00116371909841
Individual [popg] 0.00115829331784
Risks [qlco] 0.00115490923364
Low Density Lipoprotein Cholesterol [bacs, strd] 0.00115315993672
Provide [acty] 0.0011524669167
development [phsf] 0.00114846514155
Daily [tmco] 0.00114045476107
In [qnco] 0.00113517621851
Combination [qlco] 0.00113085804603
Make [ftcn] 0.00113005912883
Guidelines [inpr] 0.00112988376847
Heart disease [dsyn] 0.00112639989577
Approach [spco] 0.00112012720851
Often [tmco] 0.00111649041121
tibolone [phsu, strd] 0.0011084557529
condition [dsyn] 0.00110737000991
Sclerotherapy [topp] 0.00110658231589
Care [acty] 0.00110480509458
Estrogens [horm, phsu, strd] 0.00110129772054
hypertensive [fndg] 0.00110010809038
Plus [qlco] 0.0010902615304
Endothelial [tisu] 0.001087457904
Mechanisms [ftcn] 0.0010793942901
diabetic [fndg] 0.001078807784
PREVENT [phsu] 0.00107582083221
Surgery [bmod] 0.00107280633455
Diabetes Mellitus [dsyn] 0.00106655402692
Four [qnco] 0.00104384369902
Possible [qlco] 0.0010408937873
IMPACT [gngm] 0.00103533535052
Common [qnco] 0.00103109851291
Primary [qlco] 0.00102687940598
Predictor [idcn] 0.00102422307325
Transdermal [ftcn] 0.00102114583666
Serum [bdsu] 0.00101970514875
Independent [idcn] 0.00101763125752
Large [qnco] 0.00101710059492
Flow [npop] 0.00101672173706
Cholesterol, LDL [bacs, strd] 0.00101671901113
Available [ftcn] 0.00101256773332
R- [spco] 0.00100728736743
Known [qlco] 0.000999345641383
findings [ftcn] 0.000997705808624
Relationship [qlco] 0.000996728418984
Part [spco] 0.000994717082554
Hospital [hcro, mnob] 0.00099440158207
Article [inpr] 0.00098919477979
High Risk [qlco] 0.000987571532198
Therapeutic [topp] 0.000985723412847
setting [ftcn] 0.000979303771455
Quality [qlco] 0.000977482597433
Null [qnco] 0.000968939669265
Dependent [qlco] 0.00095955857372
Following [tmco] 0.000959256164831
activity [dora] 0.000956618126701
function [phsf] 0.000953854520362
Triglycerides [bacs, lipd] 0.000944302911832
low [qlco] 0.000943346868117
Concern [idcn] 0.000940784958597
Complications [patf] 0.000939143214162
objectives [inpr] 0.000932083876218
Equine [mamm] 0.000931914840182
Life [idcn] 0.000928319962512
Odds Ratio [qnco] 0.000923751280188
Future [tmco] 0.0009209893181
Average [qnco] 0.000920715512257
days [tmco] 0.000916890319493
Strong [qlco] 0.000913194795915
Administration [ocac] 0.000912391946202
Examined [fndg] 0.000907133583614
vascular [bpoc] 0.000906165165603
Ireland [geoa] 0.000905107121318
experience [menp] 0.00090413964497
Diagnosis [fndg] 0.000896834504349
Main [qlco] 0.000894222950143
mediated [socb] 0.000893239154383
Dyslipidaemia [dsyn] 0.000892582040624
Information [idcn] 0.000891200314022
Overall [inpr] 0.000890154966699
Cohort [popg] 0.000889412383686
Relative Risk [qnco] 0.000889268042303
Increasing [ftcn] 0.000879050941051
Agent [chvf] 0.000876646642017
Secondary Prevention [topp] 0.000876629495877
Statin [orch, phsu] 0.000874734770379
I- [inch] 0.00087353798127
Endothelium [tisu] 0.00087101739456
investigated [ftcn] 0.000869010733976
ischaemic heart disease [dsyn] 0.000868718464543
Ratio [qnco] 0.000867533957475
Continuous [idcn] 0.000865799918822
Primary Prevention [topp] 0.000864272412566
Affect [menp] 0.000849190191299
participants [popg] 0.000845866669178
Addition [ftcn] 0.000843350108316
Need [qlco] 0.00083727303922
Sex [orgf] 0.000834911099504
Well [qlco] 0.0008329299725
symptoms [ftcn] 0.000831225975641
Presence [topp] 0.000830777936428
Safety [hcpp] 0.000826119998794
APPEAR [qlco] 0.000824162586953
Needed [qlco] 0.000821949243457
Smoking [inbe] 0.000821434900863
influential [idcn] 0.000820655528726
cardiovascular risk factor [dsyn] 0.000814128478894
Morbidity [qnco] 0.000812502672004
variables [qlco] 0.000810550049483
Likely [qlco] 0.00080799408111
Estrogen Replacement Therapy [topp] 0.000806327968096
Low density lipoprotein [aapp, bacs, lipd] 0.000804183699496
Physicians [prog] 0.000799414780467
Compare [acty] 0.000798851077471
Conjugated Equine Estrogens [horm, phsu, strd] 0.000794308346516
Recently [tmco] 0.00079306259134
Clinical Trials [resa] 0.0007824317696
Various [irda] 0.000775293215083
Cardiac [bpoc] 0.000775222704337
HRT [topp] 0.000774999916512
Response [orga] 0.000774388338829
Conduct [inbe] 0.000774079353923
Better [qlco] 0.000773213850312
median [spco] 0.000768239488797
cardiovascular events [fndg] 0.000766775192346
Duration [tmco] 0.000766269200011
Reported [inpr] 0.000766201917845
Altered [ftcn] 0.000764826214681
Progesterone [horm, phsu, strd] 0.000762448076413
Risk factor [qnco] 0.000758675144542
Published [ocac] 0.000757958723615
Alternative [cnce] 0.000757112119329
Same [qlco] 0.000755173068455
Index [inpr] 0.000754392044749
Now [tmco] 0.000752220046738
Initial [tmco] 0.000749095501201
Model [inpr] 0.000748038168464
Evaluation [ftcn] 0.00074749175117
progression [patf] 0.000747467248251
Favorable [qlco] 0.000745606553435
acute [tmco] 0.000743608426196
Area [geoa] 0.000743363312231
Five [qnco] 0.000743202253074
Hypercholesterolaemia [dsyn] 0.000742705903726
Exercise [dora] 0.000742285325651
???lead [elii, hops] 0.000738780616668
Lp(a) [aapp, bacs] 0.00073831055884
Direct [qlco] 0.000734231348294
national [inpr] 0.000729374483496
Type [qlco] 0.000729327130286
Report [inpr] 0.000726048522967
investigate [ftcn] 0.000725588321035
Ii [aapp] 0.00071887617519
premenopausal [tmco] 0.000717697047072
Cancer [neop] 0.000713595037052
If [qlco] 0.000712020545751
Seen [qlco] 0.0007116522915
Estrogen Replacement [topp] 0.00071121839064
Insulin [aapp, horm, phsu] 0.000710415911886
Single [popg] 0.000710116825848
homocysteine [aapp, bacs] 0.000707879772548
Interaction [ftcn] 0.000704006008097
Measure [qnco] 0.00070374260926
recommendations [idcn] 0.000702961609509
Recommended [idcn] 0.000700723627661
GIVEN [cnce] 0.000700318374615
Medication [phsu] 0.000698182120967
regimens [inpr] 0.000694705351621
Complex [qlco] 0.000692926475852
Status [qlco] 0.000692685540454
Fasting [fndg] 0.00069035047363
Heart [bpoc] 0.000689729996958
Goal [inpr] 0.000689112655136
month [tmco] 0.000688526484341
Severe [qlco] 0.000686573472033
Relative [famg] 0.00068575534523
Value [qnco] 0.000685269612114
Cost [qnco] 0.000684991119113
Cost Effectiveness [qnco] 0.000681395415033
Atrial Fibrillation [patf] 0.000680855762074
Obesity [dsyn] 0.000678767080703
Support [medd] 0.000676223069013
Additional [ftcn] 0.000675764576492
Controlled [ftcn] 0.000673976238919
Characteristics [qlco] 0.000669949214455
Long [qlco] 0.000669805117885
Young [tmco] 0.000669736035501
Purpose [ftcn] 0.000666208915142
Defined [cnce] 0.000665897840694
practice [menp] 0.000660629295942
mmol/L [qnco] 0.000658882530188
Damage [inpo] 0.000658290873568
Occurred [acty] 0.000656349889168
atherosclerotic [ftcn] 0.000655989361056
Fibrinogen [aapp, bacs, phsu] 0.000655193668505
frequency [qnco] 0.000649698406978
Adjustment [inbe] 0.000646317174031
Systolic [tmco] 0.000644781929512
Select [acty] 0.000643567584209
hormone replacement [topp] 0.000642089005851
prospective [resa] 0.000641077463633
Past [tmco] 0.000638793100152
Correlation [qlco] 0.000633759924886
DOUBLE BLIND [resa] 0.000633414116658
Literature [inpr] 0.000632788917451
Few [qnco] 0.000630286248439
Life Style [socb] 0.000630081187257
radiotherapy [inpr] 0.000628664062842
Lipoprotein [aapp, bacs] 0.000628264975749
Echocardiography [diap] 0.000627982781815
Survival [acty] 0.000627917970196
Lipids [lipd] 0.000626272324179
Help [socb] 0.000626263829664
mg day [qnco] 0.000623599636481
Identified [qlco] 0.000620895072917
Comparison [acty] 0.000619009199187
Out [spco] 0.000616847568102
Myocardial [spco] 0.000615954932677
Administered [ftcn] 0.000615719182229
Overweight [sosy] 0.000615025251495
Previous [tmco] 0.000613856893753
Progestagen [horm, phsu, strd] 0.000610758949474
Reducing [qlco] 0.000610087688292
Little NOS [cgab, dsyn] 0.000609560084435
Cycle [tmco] 0.000608833569049
Target [ftcn] 0.000607989461877
Currently [tmco] 0.000604817554623
Required [ftcn] 0.000604440359208
Issue [fndg] 0.000603236221644
admission [hlca] 0.000594381351813
choice [inbe] 0.000592180190482
Normal [qlco] 0.000591866651008
measurements [ftcn] 0.000588954674248
Replacement [topp] 0.00058665278039
Contribute [acty] 0.000585803281261
Diseases [dsyn] 0.000584575727079
Tamoxifen [orch, phsu] 0.000583993553527
Coronary heart disease risk [inpr] 0.000577791065651
Normotensive [fndg] 0.000576676606652
rats [mamm] 0.000576598451723
Menopausal [phsf] 0.000575626079047
reductions [npop] 0.000574902068932
Very [qlco] 0.000574390760139
Onset [qlco] 0.000573451414142
Link [inpr] 0.000573117845059
matched [resa] 0.000572178788816
Education [edac] 0.000571314950919
Sample [sbst] 0.000569609433963
Diagnosed [fndg] 0.000568335578463
chronic [tmco] 0.000567999351107
Treatments [topp] 0.000566171356632
Blood [tisu] 0.000565221305062
Cl - [elii] 0.000564238638145
High density lipoprotein [aapp, bacs, lipd] 0.000563977485895
Consecutive [qlco] 0.00056321299381
Calcium [bacs, elii, phsu] 0.000563041095489
Breast [bpoc] 0.000562729409312
Periodontitis [dsyn] 0.000562344561908
Heart failure [dsyn] 0.000560409809354
Selective Estrogen Receptor Modulators [horm, phsu] 0.000558376899028
Radiation [npop] 0.000558337752244
Lipoproteins [aapp, bacs] 0.000555150113012
weight [orga] 0.000554780074617
Venous malformation [anab] 0.000552044554388
Female [fndg] 0.00055171481382
strategies [menp] 0.00055150059901
History [ocdi] 0.000550744162238
Certain [qlco] 0.000550668083081
Woman [popg] 0.000550408925171
Late [tmco] 0.000548760915572
Method [inpr] 0.000545582512258
Obtained [ftcn] 0.000544374027353
Severity [qlco] 0.000542254601834
Glucose [bacs, carb, phsu] 0.000541725184691
People [popg] 0.000541711346017
Assigned [ftcn] 0.000541584529483
Small [qnco] 0.000541559061512
Arterial [bpoc] 0.000540472819507
Congestive heart failure [dsyn] 0.000540076388903
Multiple [qnco] 0.000537063722358
adverse effects [ftcn] 0.000536137171268
Lipoprotein (a) [aapp, bacs] 0.000533812006171
H+ [elii] 0.000532551041122
System [ftcn] 0.000531096513625
Address [inpr] 0.000527397099925
Proven [qlco] 0.000525419828899
Frequently [tmco] 0.000522875233549
secondary [neop] 0.000519136697422
Six [qnco] 0.00051899515642
Appropriate [qlco] 0.000518583099511
Elevated [qlco] 0.000518582219576
Low dose [qnco] 0.000515465504242
Post-Menopause [orgf] 0.000515188740165
End Point [qlco] 0.000511512214836
cholesterol levels [lbpr] 0.000510261462681
glycemia [carb] 0.000508722410901
Measures [qnco] 0.000506837772077
Occur [acty] 0.000504495728385
Percent [qnco] 0.000504478467588
Observational Study [resa] 0.000504167356065
Hormone [horm] 0.000503636131331
Assessment [hlca] 0.000502710110833
Prognostic Factor [clna] 0.000500844176667
Active [ftcn] 0.000500619222954
Indicated [fndg] 0.000499501723796
Cells [cell] 0.000498591316793
Persons [popg] 0.000497631495341
Natural [ftcn] 0.000497095289593
Inflammation [patf] 0.000496038562729
Associations [menp] 0.000495777563002
Hyperlipidaemia [dsyn] 0.000495607698849
Depression [mobd] 0.000495570702001
topic2
Estrogen [horm, phsu, strd] 0.00629666632043
N NOS [aapp, imft] 0.00356828071817
placebo [topp] 0.00316127985057
Myocardial Infarction [dsyn] 0.00283241936645
Blood Pressure [orgf] 0.00270573505224
Raloxifene [orch, phsu] 0.00265104101294
Men [popg] 0.00258810666146
mg% [qnco] 0.00238694672358
Menopause [phsf] 0.00234886303754
C-reactive protein [aapp, imft] 0.00228711426297
Plasma [bdsu] 0.00225854862131
Lipid [lipd] 0.00213368732813
Combined [qlco] 0.00212594678059
Cholesterol [bacs, strd] 0.00208448956951
Osteoporosis [dsyn] 0.00207631288412
Breast Cancer [neop] 0.00206963114192
Measured [qlco] 0.002062988012
Incidence [qnco] 0.00200548081835
Change [ftcn] 0.00196428200023
Similar [qlco] 0.00196305455611
Oral [spco] 0.00195598477551
coronary [bpoc] 0.00192038259406
Diabetes [dsyn] 0.00191828739491
Science [ocdi] 0.00189307701771
Atherosclerosis [dsyn] 0.00184919199934
Non [ftcn] 0.00182928980103
Drug [phsu] 0.0018244478823
Subject [grup] 0.00181374935478
Profile [lbpr] 0.00179240967005
Old [tmco] 0.00173795928514
Events [evnt] 0.00172123028029
coronary artery disease [dsyn] 0.00171018664842
Recent [tmco] 0.00169230073356
Association [menp] 0.00166539555379
Benefit [qnco] 0.00161469622795
Received [qlco] 0.00159489006354
Drugs [phsu] 0.00159056223038
Drug Therapy [topp] 0.00156476992498
Individual [popg] 0.00155783368856
Decreased [qnco] 0.00155780689163
Current [tmco] 0.00155734775521
randomized [resa] 0.00153173183717
function [phsf] 0.0015277207673
Dose [qnco] 0.00151802989723
Receive [qlco] 0.00150212259601
Provide [acty] 0.00149726836966
Acute myocardial infarction [dsyn] 0.00148898487624
Estradiol [horm, phsu, strd] 0.0014765894226
Early [tmco] 0.00144095314698
Response [orga] 0.00143912588149
Confidence Interval [qnco] 0.00143231943096
Take [hlca] 0.00142470568497
Statins [orch, phsu] 0.00140470368216
Decrease [qlco] 0.00140209090257
mg dl [qnco] 0.0013973560285
LTD [ortf] 0.00138909812252
development [phsf] 0.00138306977604
mmHg [qnco] 0.00137169245796
Several [qnco] 0.00136805533645
Serum [bdsu] 0.00135797952941
Assess [acty] 0.00135056908184
days [tmco] 0.00133770945335
PREVENT [phsu] 0.00131790207557
Estrogens [horm, phsu, strd] 0.00131218238146
Primary [qlco] 0.00131131066952
Endothelial [tisu] 0.00130066247228
Secondary Prevention [topp] 0.00129063433265
Progestin [horm, phsu, strd] 0.0012851630314
Assessed [acty] 0.00127690467748
Users [humn] 0.00127411886325
Large [qnco] 0.00127075158281
Dependent [qlco] 0.00126667777456
High Density Lipoprotein Cholesterol [bacs, lipd] 0.00126553511835
Induced [ftcn] 0.00126098543422
Total Cholesterol [lbpr] 0.00124015123398
intervention [hlca] 0.00124009560046
Following [tmco] 0.00123773559451
High Risk [qlco] 0.00123596506509
Quality [qlco] 0.00122179458192
Plus [qlco] 0.00121794672588
Well [qlco] 0.00120688773402
Aged [orga] 0.00118659606195
Cases [ftcn] 0.00118280484431
Specific [qlco] 0.00118019260226
Alone [qnco] 0.00117337763128
IMPACT [gngm] 0.00117171552916
Stroke [dsyn] 0.00116636295868
Body Mass Index [diap] 0.00115243697678
Cardiac [bpoc] 0.00115083659772
Concentrations [menp] 0.00114741149749
Various [irda] 0.00114572839632
Benefits [qnco] 0.00114416474676
Known [qlco] 0.00114006695162
Hospital [hcro, mnob] 0.00113919845867
considered [idcn] 0.00113511453368
APPEAR [qlco] 0.00113446027546
mediated [socb] 0.00113284798507
weeks [tmco] 0.00112968719546
Reported [inpr] 0.00112132952204
lowering [spco] 0.00112122645114
Duration [tmco] 0.00112077360739
Values [qlco] 0.00111079410197
Common [qnco] 0.00110693385258
cardiovascular risk factor [dsyn] 0.00110376140732
Surgery [bmod] 0.00109579997962
setting [ftcn] 0.00109388676609
Often [tmco] 0.00109259526985
medroxyprogesterone acetate [horm, phsu, strd] 0.00108931974917
Continuous [idcn] 0.0010880778068
Flow [npop] 0.00108784040667
Agent [chvf] 0.00108124877171
Established [qlco] 0.00107948324786
Guidelines [inpr] 0.00107466667788
R- [spco] 0.00107462073133
acute [tmco] 0.00106493949393
Administration [ocac] 0.00106033396976
Transdermal [ftcn] 0.00105609976284
Equal [qlco] 0.00105358395994
Care [acty] 0.00105282877803
Presence [topp] 0.00105205111234
I- [inch] 0.00104552380318
Prevalence [qnco] 0.00103961096913
Low Density Lipoprotein Cholesterol [bacs, strd] 0.0010383243898
Heart [bpoc] 0.00103054519952
In [qnco] 0.00102011203879
Therapeutic [topp] 0.00101704124419
findings [ftcn] 0.0010131959319
Independent [idcn] 0.00100486168739
Death [orgf] 0.00100312717218
Addition [ftcn] 0.00100277942801
Equine [mamm] 0.000996243381854
Overall [inpr] 0.000984221462822
Risk factor [qnco] 0.000977675357246
Range [qnco] 0.000974472233774
Exercise [dora] 0.000972135552511
activity [dora] 0.000967291163259
Aspirin [orch, phsu] 0.000965779523455
Four [qnco] 0.000963128188466
Conjugated estrogen [horm, phsu, strd] 0.000962733377372
national [inpr] 0.000953720958202
Available [ftcn] 0.00095367327752
Ireland [geoa] 0.000951793713087
Evaluated [ftcn] 0.000951703881662
Information [idcn] 0.000950590610665
Increasing [ftcn] 0.000949341038586
Echocardiography [diap] 0.000941976590316
Initial [tmco] 0.000938459651366
Odds Ratio [qnco] 0.0009365960281
HRT [topp] 0.000935047361992
Diet [food] 0.000932515127485
Marker [clna] 0.000931481396487
High density lipoprotein [aapp, bacs, lipd] 0.000926103668455
diabetic [fndg] 0.000925738737503
Statin [orch, phsu] 0.00092500939382
Medical [ftcn] 0.000924013444777
Cholesterol, LDL [bacs, strd] 0.000922954079907
Affect [menp] 0.000914515390188
Mechanisms [ftcn] 0.000910688149425
History [ocdi] 0.000907066072608
Comparison [acty] 0.000904628374534
Life [idcn] 0.000899074026902
hypertensive [fndg] 0.000898372792526
Predictor [idcn] 0.000895582960191
Triglycerides [bacs, lipd] 0.000893521080815
Hypercholesterolaemia [dsyn] 0.000891175218462
Value [qnco] 0.00088910925916
Recommended [idcn] 0.000883803731792
progression [patf] 0.00088272849606
Conduct [inbe] 0.000882714210842
homocysteine [aapp, bacs] 0.000882560760418
Cancer [neop] 0.000879906726817
tibolone [phsu, strd] 0.000879178836578
Tamoxifen [orch, phsu] 0.000879037905033
Purpose [ftcn] 0.000874362707026
Combination [qlco] 0.000869441162627
Survival [acty] 0.00086718768535
low [qlco] 0.000852347563182
Approach [spco] 0.000848871292209
Compare [acty] 0.000848380074055
Cohort [popg] 0.000847594729564
Primary Prevention [topp] 0.000845520960737
Improvement [cnce] 0.000845181658391
Diagnosis [fndg] 0.000842948633123
Heart disease [dsyn] 0.000838022319615
Ratio [qnco] 0.000837749453487
Possible [qlco] 0.000835416286145
Strong [qlco] 0.000835296694039
Conjugated Equine Estrogens [horm, phsu, strd] 0.000833822159904
symptoms [ftcn] 0.000831748603353
practice [menp] 0.000831068120798
Needed [qlco] 0.000825757957353
cardiovascular events [fndg] 0.000821675366441
Replacement [topp] 0.000819985458956
Morbidity [qnco] 0.0008149541035
premenopausal [tmco] 0.000814561704566
Clinical Trials [resa] 0.000806577985668
recommendations [idcn] 0.000805506600625
Select [acty] 0.000800599601841
radiotherapy [inpr] 0.000800587832627
Examined [fndg] 0.000799546749235
median [spco] 0.000797901261157
Currently [tmco] 0.000796181933043
Improved [qlco] 0.000795812781354
Complications [patf] 0.000795248738057
prescribed [hlca] 0.000794254159053
Part [spco] 0.000791389640207
Relationship [qlco] 0.000788138403789
Treatments [topp] 0.000786538000154
peripheral arterial disease [dsyn] 0.000778571449871
Atrial Fibrillation [patf] 0.000775972759201
Controlled [ftcn] 0.000774728627548
Likely [qlco] 0.00077415369319
Administered [ftcn] 0.000773483017747
participants [popg] 0.000772317241158
Main [qlco] 0.000768033886556
Daily [tmco] 0.000766179329144
Endothelium [tisu] 0.000762487428361
influential [idcn] 0.000761871714835
variables [qlco] 0.000760245426699
Smoking [inbe] 0.000755790702974
Risks [qlco] 0.000751255939937
Lp(a) [aapp, bacs] 0.000747859055495
mg day [qnco] 0.000746366881481
Recently [tmco] 0.000745077701457
Lipoprotein (a) [aapp, bacs] 0.000744599549637
Five [qnco] 0.000742872035595
Diabetes Mellitus [dsyn] 0.000739647145588
investigated [ftcn] 0.000738512378688
Index [inpr] 0.000738287723391
Cost Effectiveness [qnco] 0.000736071023174
Future [tmco] 0.000735902862173
Altered [ftcn] 0.000735512672584
Support [medd] 0.000735333591428
Dyslipidaemia [dsyn] 0.000734602116282
condition [dsyn] 0.00073253179425
Parameters [fndg] 0.000732216772216
ischaemic heart disease [dsyn] 0.000731220948549
Required [ftcn] 0.000724862009855
Glucose [bacs, carb, phsu] 0.00072021527398
Woman [popg] 0.00071793152242
Alternative [cnce] 0.000717426894832
Area [geoa] 0.000717202264006
Six [qnco] 0.00071622691548
Control Group [grup] 0.000711388370587
Relative [famg] 0.000711196534795
Target [ftcn] 0.000704802888577
Make [ftcn] 0.000701984567594
Single [popg] 0.000700550826037
Assessment [hlca] 0.000696090981928
Lipoprotein [aapp, bacs] 0.000695365955685
vascular [bpoc] 0.000694087761548
hormone replacement [topp] 0.000692951673371
Measure [qnco] 0.000692525490329
Safety [hcpp] 0.000690372286158
Normal [qlco] 0.00069005434967
Normotensive [fndg] 0.000687396206489
Coronary heart disease risk [inpr] 0.000686013181212
Diseases [dsyn] 0.000683994165181
Characteristics [qlco] 0.000682508283652
Radiation [npop] 0.000682258841716
Obtained [ftcn] 0.000680610968415
Systolic [tmco] 0.000679908876165
account [idcn] 0.000677237939569
Article [inpr] 0.000677051844254
Null [qnco] 0.000675744787685
Contribute [acty] 0.000675315303588
Average [qnco] 0.00067415586753
month [tmco] 0.000672561000902
Selective Estrogen Receptor Modulators [horm, phsu] 0.000672160497161
mg/d [qnco] 0.00067046168984
Seen [qlco] 0.000670300721191
Estrogen Replacement Therapy [topp] 0.000667705002345
Cycle [tmco] 0.000667382436988
Evaluation [ftcn] 0.000667277713899
Report [inpr] 0.000666162285515
Literature [inpr] 0.000664435264139
experience [menp] 0.000663853489377
Protection [fndg] 0.000663672135443
GIVEN [cnce] 0.000661979054077
Favorable [qlco] 0.000661510677623
Previous [tmco] 0.000660641449321
Progesterone [horm, phsu, strd] 0.000660394788927
investigate [ftcn] 0.000653525767372
Past [tmco] 0.000653222594051
Need [qlco] 0.000652317132285
Direct [qlco] 0.00064883700849
System [ftcn] 0.000647556569023
End [spco] 0.000646252807005
Method [inpr] 0.000644593943484
Published [ocac] 0.000644270602864
Children [aggp] 0.000643258956399
Sclerotherapy [topp] 0.000642637480039
Occurred [acty] 0.000641820020794
Insulin [aapp, horm, phsu] 0.000641413051687
Heart failure [dsyn] 0.000639658109714
prospective [resa] 0.000639329554003
Lipoproteins [aapp, bacs] 0.00063437579497
Low density lipoprotein [aapp, bacs, lipd] 0.000633776066644
Involved [ftcn] 0.000631630219972
Long [qlco] 0.00063146528184
Hormones [horm] 0.000623765071607
regimens [inpr] 0.000623145214241
H+ [elii] 0.00062162353556
Concentration [menp] 0.000618079682094
Additional [ftcn] 0.000617855299498
Adjustment [inbe] 0.000617481836253
Help [socb] 0.000617471900946
Appropriate [qlco] 0.000616369584988
Link [inpr] 0.000614376686828
matched [resa] 0.000614255584769
Natural [ftcn] 0.000608005250721
Assigned [ftcn] 0.000605041756185
Identified [qlco] 0.000604622892292
Eight [qnco] 0.00060174723715
Better [qlco] 0.000600287821134
Order [inpr] 0.00059958039384
objectives [inpr] 0.000598515709592
Pulse Pressure [orgf] 0.000597570181538
Severe [qlco] 0.000597505533268
Percent [qnco] 0.000595977715766
Now [tmco] 0.000595010337829
Post-Menopause [orgf] 0.000594027927807
Elderly [popg] 0.000593983399848
Fibrinogen [aapp, bacs, phsu] 0.000592349544153
Cost [qnco] 0.000591179516429
Relative Risk [qnco] 0.0005903356421
trends [tmco] 0.000586371531652
Difficult [qlco] 0.000581069515607
Elevated [qlco] 0.000581064973433
If [qlco] 0.000580749449212
Multiple [qnco] 0.000580598735015
Onset [qlco] 0.000579461109078
Modification [ftcn] 0.000577567041103
Interaction [ftcn] 0.000576682998698
Concern [idcn] 0.000576462450725
Sex [orgf] 0.000576229141511
Hormone [horm] 0.000572847410951
Standard [qlco] 0.000572547797743
responses [orga] 0.000570705493164
Correlated [qlco] 0.000569481530383
DOUBLE BLIND [resa] 0.000568374122736
Arterial [bpoc] 0.000567476558714
Females [fndg] 0.000565251387099
Doses [qnco] 0.000564969368358
Damage [inpo] 0.000564524021739
Systemic [ftcn] 0.000561752166194
Calcium [bacs, elii, phsu] 0.000561392695666
Breast [bpoc] 0.00055998182864
chronic [tmco] 0.000559944734852
Status [qlco] 0.000559027169392
Cl - [elii] 0.000558663628353
Female [fndg] 0.000558031941113
Correlation [qlco] 0.000557257590729
Medication [phsu] 0.000557195397792
Therapies [topp] 0.000551046979131
measurements [ftcn] 0.000550643666374
Complex [qlco] 0.000549386017896
Norethisterone acetate [horm, phsu, strd] 0.000546124510923
Male [fndg] 0.000545617384789
Menopausal [phsf] 0.000545150031589
Leading [tmco] 0.000542815265528
Record [inpr] 0.000541097331484
Question [inpr] 0.000540114711041
Observational Study [resa] 0.000539873922488
Intima media thickness [clna] 0.000538923417148
Bone Mineral Density [clna] 0.000538840524311
Expression [topp] 0.00053744421206
Costs [qnco] 0.000536122341874
Reducing [qlco] 0.000534706395905
atherosclerotic [ftcn] 0.000534034148521
menopausal symptoms [sosy] 0.00053243051217
Hormone Replacement Therapy, Post-Menopausal [topp] 0.000532025482473
secondary [neop] 0.000528118584515
Life Style [socb] 0.000527563583918
society [orgt] 0.000527522414682
Physicians [prog] 0.000522982841516
Congestive heart failure [dsyn] 0.000522074447763
Adults [aggp] 0.000522030852421
Dietary [food] 0.000521860831597
adverse effects [ftcn] 0.000519326385412
Limited [ftcn] 0.000518304798887
Goal [inpr] 0.000517839761984
Proven [qlco] 0.000517705418259
Compound [qlco] 0.000515288859138
Little NOS [cgab, dsyn] 0.000515175347248
Severity [qlco] 0.000514376550729
Fatal [qlco] 0.000513377490726
Obesity [dsyn] 0.000513144149186
Myocardial [spco] 0.000512167490738
Prognostic Factor [clna] 0.000511671900447
Model [inpr] 0.000510202609273
Type [qlco] 0.00050719656374
interventions [hlca] 0.000505910759572
reductions [npop] 0.000505895292664
Inflammation [patf] 0.000505703563449
placebo-controlled [resa] 0.00050476328981
Wide [spco] 0.000502748451691
Class [inpr] 0.000501168256378
People [popg] 0.00050033313869
Beta-Blockers [phsu] 0.000498816942436
topic3
Estrogen [horm, phsu, strd] 0.00379039326583
N NOS [aapp, imft] 0.00331211999813
mg% [qnco] 0.00284488643588
placebo [topp] 0.00281560862964
Men [popg] 0.00278790690516
Menopause [phsf] 0.00272554894909
Estradiol [horm, phsu, strd] 0.00243268483475
Blood Pressure [orgf] 0.0024187056107
Breast Cancer [neop] 0.00235039012144
Old [tmco] 0.00234270931562
Atherosclerosis [dsyn] 0.00222205943135
C-reactive protein [aapp, imft] 0.0022040483516
Lipid [lipd] 0.00213823007315
Raloxifene [orch, phsu] 0.00211313552875
Oral [spco] 0.00210206044936
Incidence [qnco] 0.00208517762888
Decreased [qnco] 0.0020596417741
Myocardial Infarction [dsyn] 0.0020554427082
Combined [qlco] 0.00196168252167
Subject [grup] 0.00188625590666
Measured [qlco] 0.00187312984827
Diabetes [dsyn] 0.00187129822688
Receive [qlco] 0.00186668631879
Induced [ftcn] 0.00184322539757
Decrease [qlco] 0.00181196011058
Death [orgf] 0.00177974983429
Similar [qlco] 0.00176052013666
coronary [bpoc] 0.00175758927984
randomized [resa] 0.00174751815607
Drug Therapy [topp] 0.00174633280755
Change [ftcn] 0.00172599084717
Osteoporosis [dsyn] 0.00172327724428
coronary artery disease [dsyn] 0.00167304498754
Early [tmco] 0.00167279371814
Events [evnt] 0.00162955698397
mmHg [qnco] 0.00162754778225
Stroke [dsyn] 0.0016225147913
Range [qnco] 0.00160794035525
Received [qlco] 0.00160539201773
Acute myocardial infarction [dsyn] 0.00158571130018
Cholesterol [bacs, strd] 0.00158287489416
Science [ocdi] 0.00155262470252
Drug [phsu] 0.00152487217485
Drugs [phsu] 0.0015001591189
Plasma [bdsu] 0.00149499572854
Benefit [qnco] 0.00149296760174
Estrogens [horm, phsu, strd] 0.00144503712078
PREVENT [phsu] 0.00141830924752
hypertensive [fndg] 0.00140218400376
Diet [food] 0.00140170784082
Concentrations [menp] 0.00139562640698
Cases [ftcn] 0.00137231006514
Profile [lbpr] 0.00136917143434
mg dl [qnco] 0.00135123253904
Care [acty] 0.0013462639654
Individual [popg] 0.00132241789125
Assess [acty] 0.00131727642392
function [phsf] 0.00130770571437
Take [hlca] 0.00130147303459
weeks [tmco] 0.00129522466142
Users [humn] 0.00128876831618
Several [qnco] 0.00128361434164
Aged [orga] 0.00128176766086
Common [qnco] 0.00127711985375
Association [menp] 0.00127481808006
IMPACT [gngm] 0.00127028363372
Conjugated estrogen [horm, phsu, strd] 0.00125935381791
Equal [qlco] 0.00125879877612
HRT [topp] 0.00125040243515
Guidelines [inpr] 0.00124995424238
Plus [qlco] 0.00124040471957
Statins [orch, phsu] 0.00123776410568
Provide [acty] 0.00122826215455
Reported [inpr] 0.00122369733322
Assessed [acty] 0.00121562462584
Dose [qnco] 0.00121323469305
lowering [spco] 0.00120718348226
Available [ftcn] 0.00120712596399
Often [tmco] 0.00120431922706
Average [qnco] 0.00120347091385
Body Mass Index [diap] 0.00120291687374
Endothelial [tisu] 0.00120188589942
setting [ftcn] 0.00120113395927
Predictor [idcn] 0.00119197011739
High Risk [qlco] 0.00119095698327
Known [qlco] 0.00119001438963
experience [menp] 0.00118694014752
Recent [tmco] 0.00117573887535
considered [idcn] 0.00117298609302
cardiovascular risk factor [dsyn] 0.00117032975888
Dependent [qlco] 0.00115925901817
Exercise [dora] 0.00115713682372
Continuous [idcn] 0.00115677119745
Administration [ocac] 0.00115402717974
Primary [qlco] 0.0011530238999
Progestin [horm, phsu, strd] 0.00115295017831
Total Cholesterol [lbpr] 0.00114279172646
Estrogen Replacement Therapy [topp] 0.00113320901375
Non [ftcn] 0.00112556263435
Independent [idcn] 0.00112275941326
Benefits [qnco] 0.00112151774552
Agent [chvf] 0.00111501042428
Serum [bdsu] 0.00110372940179
development [phsf] 0.00110091267271
Combination [qlco] 0.00109965528274
Prevalence [qnco] 0.00109874884451
Well [qlco] 0.00109727284512
Therapeutic [topp] 0.00109394185056
symptoms [ftcn] 0.0010848027556
diabetic [fndg] 0.0010808205771
Cholesterol, LDL [bacs, strd] 0.00107755937064
condition [dsyn] 0.00107537947367
low [qlco] 0.00106744967248
vascular [bpoc] 0.00105708826487
recommendations [idcn] 0.00105306976113
progression [patf] 0.00105045082555
Primary Prevention [topp] 0.00104401635977
intervention [hlca] 0.00104213151318
Transdermal [ftcn] 0.00103108569421
Approach [spco] 0.00102196207379
Statin [orch, phsu] 0.00102104711764
Low Density Lipoprotein Cholesterol [bacs, strd] 0.00101482170017
Confidence Interval [qnco] 0.00101266203275
Need [qlco] 0.00101022454788
Hospital [hcro, mnob] 0.00100239421971
findings [ftcn] 0.00100204769701
national [inpr] 0.00100176874217
mediated [socb] 0.000996647875742
Aspirin [orch, phsu] 0.000996628838187
Information [idcn] 0.000995014109246
Current [tmco] 0.000994804934301
Insulin [aapp, horm, phsu] 0.000991759787708
Increasing [ftcn] 0.000987073315412
High Density Lipoprotein Cholesterol [bacs, lipd] 0.000985109168663
Heart [bpoc] 0.000983110555812
Complications [patf] 0.000978423801628
Smoking [inbe] 0.000973174452319
Flow [npop] 0.00097250585685
medroxyprogesterone acetate [horm, phsu, strd] 0.000972394529362
LTD [ortf] 0.000970335463342
activity [dora] 0.000967037443576
Triglycerides [bacs, lipd] 0.000964345851579
tibolone [phsu, strd] 0.000962938706794
Quality [qlco] 0.000956954952738
Following [tmco] 0.000951887986328
Comparison [acty] 0.00095107832124
Duration [tmco] 0.000950773814562
Medical [ftcn] 0.000950242347108
Ireland [geoa] 0.000943231921429
Evaluated [ftcn] 0.000941696356447
Same [qlco] 0.00094071237682
Diabetes Mellitus [dsyn] 0.000940230089052
Possible [qlco] 0.0009380242175
Examined [fndg] 0.000934188146933
Values [qlco] 0.000931648362574
Large [qnco] 0.000930863237111
R- [spco] 0.000927692426186
acute [tmco] 0.000918799883949
Purpose [ftcn] 0.000918086013009
investigated [ftcn] 0.000915607672081
Sclerotherapy [topp] 0.000915185552497
practice [menp] 0.000914171494837
APPEAR [qlco] 0.000912525343064
Characteristics [qlco] 0.000909555325286
Literature [inpr] 0.000909173882194
Future [tmco] 0.000907625571564
Alone [qnco] 0.000898561953146
Established [qlco] 0.000897856298619
Improvement [cnce] 0.00089716572262
Concern [idcn] 0.000892046137879
Addition [ftcn] 0.000891426627511
Elderly [popg] 0.000890461246295
Likely [qlco] 0.000887170029098
Main [qlco] 0.000882794022773
Equine [mamm] 0.000874093276816
Status [qlco] 0.000873842305902
Diagnosis [fndg] 0.000873155505166
Needed [qlco] 0.000865193956754
Affect [menp] 0.000862429627299
I- [inch] 0.000858646319013
Secondary Prevention [topp] 0.000857567073228
Morbidity [qnco] 0.000854351729337
Odds Ratio [qnco] 0.000853755387475
Assessment [hlca] 0.000845498286441
Heart disease [dsyn] 0.000845076538238
Specific [qlco] 0.000844739188562
Conduct [inbe] 0.000843760194875
Complex [qlco] 0.00084338707825
days [tmco] 0.000843351083221
ischaemic heart disease [dsyn] 0.000840012225159
Index [inpr] 0.00082679908162
Published [ocac] 0.000825083325993
measurements [ftcn] 0.000825059256466
Four [qnco] 0.000823874133544
influential [idcn] 0.000821790553797
homocysteine [aapp, bacs] 0.000821385190165
Additional [ftcn] 0.000820416864895
Heart failure [dsyn] 0.000819433824298
Strong [qlco] 0.000818610392713
High density lipoprotein [aapp, bacs, lipd] 0.000818600031235
Part [spco] 0.000815261337769
reviewed [inpr] 0.000814727807419
Previous [tmco] 0.000814556186243
Altered [ftcn] 0.000810997417966
Parameters [fndg] 0.000809531076923
Clinical Trials [resa] 0.000808151822512
Safety [hcpp] 0.000806802616963
Marker [clna] 0.000806285017219
Null [qnco] 0.000805861153058
Obtained [ftcn] 0.000804791469328
Normal [qlco] 0.000803636705776
Response [orga] 0.000798520195655
Recommended [idcn] 0.000797358814993
Surgery [bmod] 0.000794747508549
median [spco] 0.000793757771117
Required [ftcn] 0.000792470637906
Dyslipidaemia [dsyn] 0.000792085020495
Cohort [popg] 0.000789679951606
Cost Effectiveness [qnco] 0.000788131770546
Target [ftcn] 0.000787813211878
mg day [qnco] 0.0007875322195
Report [inpr] 0.000787166344719
Recently [tmco] 0.00078574343205
Daily [tmco] 0.000781406158591
Value [qnco] 0.000780118944406
Make [ftcn] 0.000776248904121
Low density lipoprotein [aapp, bacs, lipd] 0.00077063313681
Administered [ftcn] 0.000770628258603
Currently [tmco] 0.000770061785415
Fibrinogen [aapp, bacs, phsu] 0.000766690284779
Initial [tmco] 0.000766595330563
objectives [inpr] 0.000762256431935
Article [inpr] 0.000755119332369
Select [acty] 0.000744428784082
Hypercholesterolaemia [dsyn] 0.000743770143069
Survival [acty] 0.000740061460901
Control Group [grup] 0.000740049941746
investigate [ftcn] 0.000739268278324
Echocardiography [diap] 0.000738356804788
Five [qnco] 0.000730515084257
Damage [inpo] 0.000729828999537
Cardiac [bpoc] 0.000726623476839
Overall [inpr] 0.000725882335228
Severe [qlco] 0.000724958672848
Lp(a) [aapp, bacs] 0.00072468940336
Physicians [prog] 0.000722758428608
History [ocdi] 0.00072055887901
Arterial [bpoc] 0.000720069618277
Relative Risk [qnco] 0.000715585722248
Presence [topp] 0.00071270568438
Progestagen [horm, phsu, strd] 0.000712040604237
side effects [ftcn] 0.000710238528514
cardiovascular events [fndg] 0.000709813888356
Reducing [qlco] 0.000709155049145
Elevated [qlco] 0.000708421747606
Out [spco] 0.000701353227364
Risks [qlco] 0.000697065297522
Method [inpr] 0.000693007397462
Appropriate [qlco] 0.000691401645273
Measure [qnco] 0.000688417125677
H+ [elii] 0.000687518929363
Lipoprotein (a) [aapp, bacs] 0.000686367334642
radiotherapy [inpr] 0.0006860666786
Cancer [neop] 0.000683646299802
Selective Estrogen Receptor Modulators [horm, phsu] 0.00068345769808
Mechanisms [ftcn] 0.000682682139929
Six [qnco] 0.000681153140382
Obesity [dsyn] 0.000680826463612
Life [idcn] 0.000678463368603
hormone replacement [topp] 0.000678205990264
Estrogen Replacement [topp] 0.000677987898316
participants [popg] 0.000677712024733
Atrial Fibrillation [patf] 0.000676795699382
Evaluation [ftcn] 0.000672322443047
In [qnco] 0.000671908739334
Wall [mnob] 0.000669856791339
Diseases [dsyn] 0.000669251698131
Various [irda] 0.000666923976108
Controlled [ftcn] 0.000666106183388
Model [inpr] 0.000664876110256
Relationship [qlco] 0.000663119381179
regimens [inpr] 0.000662587745133
Sex [orgf] 0.000661776731265
Better [qlco] 0.000659819772965
Life Style [socb] 0.000659683010747
placebo-controlled [resa] 0.000650310953665
Cycle [tmco] 0.000646716119081
Improved [qlco] 0.000643933303864
Assigned [ftcn] 0.000643830465877
Systolic [tmco] 0.000641796635633
peripheral arterial disease [dsyn] 0.000641376638913
month [tmco] 0.000641181660475
Nitric Oxide [bacs, inch, phsu] 0.000638870959426
Lipids [lipd] 0.000638290463165
Alternative [cnce] 0.000635493977729
Replacement [topp] 0.000635303593966
Risk factor [qnco] 0.000634266965257
With [qlco] 0.000633838893722
GIVEN [cnce] 0.000633747747069
frequency [qnco] 0.000631467499528
Lipoprotein [aapp, bacs] 0.00063053827476
Relative [famg] 0.00063027549191
Support [medd] 0.000630216878877
prospective [resa] 0.000629587110665
Progesterone [horm, phsu, strd] 0.00062828410915
Calcium [bacs, elii, phsu] 0.000628170604181
Favorable [qlco] 0.000624584475564
Goal [inpr] 0.000622495041718
Issue [fndg] 0.0006212815024
Compare [acty] 0.000621047100926
mmol/L [qnco] 0.000617294055811
Eight [qnco] 0.000609999733323
Contribute [acty] 0.000607300176842
End [spco] 0.000606545438174
Single [popg] 0.000606229416682
Type [qlco] 0.000603304846455
Percent [qnco] 0.000603225629481
Few [qnco] 0.000601755488862
Frequently [tmco] 0.000600132261507
Seen [qlco] 0.000593020313939
Woman [popg] 0.000591193068818
Young [tmco] 0.000586192268625
Diastolic blood pressure [clna] 0.000585218909045
Hormone [horm] 0.000582681293187
Class [inpr] 0.000582200897169
Past [tmco] 0.000582041237282
Venous [bpoc] 0.000577420287505
atherosclerotic [ftcn] 0.000577392727022
Initiate [idcn] 0.00057734176671
Direct [qlco] 0.000575857828658
Children [aggp] 0.000574989779342
Ratio [qnco] 0.00057244657432
Help [socb] 0.000572430634587
Severity [qlco] 0.000572400285127
Tamoxifen [orch, phsu] 0.000569994361196
premenopausal [tmco] 0.00056900192016
account [idcn] 0.000567876450476
Menopausal [phsf] 0.000567499019464
DOUBLE BLIND [resa] 0.000567229879109
Indicated [fndg] 0.000565537358857
Correlation [qlco] 0.000561432687276
Involved [ftcn] 0.000561016376292
variables [qlco] 0.000560126350945
Congestive heart failure [dsyn] 0.000559703515418
Dietary [food] 0.000558418632451
Correlated [qlco] 0.000558201788577
Male [fndg] 0.000558189830531
Copyright [inpr] 0.000557552323814
Symptomatic [ftcn] 0.000556816422702
Protection [fndg] 0.000556475188822
Question [inpr] 0.000551039902764
Inflammatory [ftcn] 0.000549385890613
Observational Study [resa] 0.000548938073641
Natural [ftcn] 0.000546657364265
reductions [npop] 0.000544553908321
Compliance [qnco] 0.000544490152359
Loss [qnco] 0.000543760315035
Ischaemic [ftcn] 0.000543484955105
Conjugated Equine Estrogens [horm, phsu, strd] 0.000542062655141
If [qlco] 0.000539466942382
Screening [hlca] 0.0005385585132
Lesion [fndg] 0.00053792837891
Breast [bpoc] 0.000536891204805
Medications [phsu] 0.000535828744296
adverse effects [ftcn] 0.000535084937014
Blood [tisu] 0.000535019821264
Ability [orga] 0.000534656002991
chronic [tmco] 0.000533622743909
Interaction [ftcn] 0.0005326296307
Venous malformation [anab] 0.000531536272982
Order [inpr] 0.000528618339817
Physical activity [dora] 0.000527528037542
Documented [hlca] 0.000527517475919
Simvastatin [orch, phsu] 0.000526752597411
Occur [acty] 0.000526676841991
Radiation [npop] 0.000525926824968
Area [geoa] 0.000525758395986
size [spco] 0.000525711023726
responses [orga] 0.000525176956985
Pulse Pressure [orgf] 0.000524442873293
Link [inpr] 0.000523251212463
Doses [qnco] 0.000519172740715
Female [fndg] 0.000519106106604
Cardiology [bmod] 0.000516323337811
Systemic [ftcn] 0.0005154175204
mg/d [qnco] 0.000513651544706
Standard [qlco] 0.000510751271489
Limited [ftcn] 0.00050898524572
Glucose [bacs, carb, phsu] 0.000508532566997
Defined [cnce] 0.000507870771758
controversies [socb] 0.000507631768761
Third [qnco] 0.000507167397581
Very [qlco] 0.000506837720064
Identified [qlco] 0.000506323355498
Endothelium [tisu] 0.000505829315956
GH [aapp, enzy] 0.000505464253212
Treatments [topp] 0.000503381905318
Late [tmco] 0.000502833562911
conclude [bodm, orch] 0.000502147549712
Play [dora] 0.000500800211508
topic4
Estrogen [horm, phsu, strd] 0.00488520809141
N NOS [aapp, imft] 0.00440822106886
Men [popg] 0.00345230970013
placebo [topp] 0.00343218775842
mg% [qnco] 0.00324331781945
Breast Cancer [neop] 0.00259269456841
Menopause [phsf] 0.00248424502651
Lipid [lipd] 0.00233286199561
Acute myocardial infarction [dsyn] 0.00232300098208
Profile [lbpr] 0.00231610564348
Raloxifene [orch, phsu] 0.00229258435815
Combined [qlco] 0.00217919383923
Myocardial Infarction [dsyn] 0.00217595788752
coronary [bpoc] 0.00202117169218
Similar [qlco] 0.00201903953205
Early [tmco] 0.00200724659973
randomized [resa] 0.00192364147529
Change [ftcn] 0.00190381437157
Decreased [qnco] 0.00190117751678
Cases [ftcn] 0.00180787602152
Progestin [horm, phsu, strd] 0.00179795665351
Non [ftcn] 0.0017811788752
Receive [qlco] 0.00176214793892
Serum [bdsu] 0.00174935864178
Events [evnt] 0.00174197324383
Plasma [bdsu] 0.00173460130704
Death [orgf] 0.00172504801695
Incidence [qnco] 0.00170323650356
Old [tmco] 0.00169212602574
Atherosclerosis [dsyn] 0.00168558332013
Oral [spco] 0.00163774635015
Cholesterol [bacs, strd] 0.00163153471696
C-reactive protein [aapp, imft] 0.00162701630417
Benefit [qnco] 0.00161678192578
Received [qlco] 0.00161394876421
Blood Pressure [orgf] 0.00161351544329
Induced [ftcn] 0.00160937127406
Stroke [dsyn] 0.00159958389735
mg dl [qnco] 0.00159817210687
Osteoporosis [dsyn] 0.00157945504213
Measured [qlco] 0.00157752067699
Subject [grup] 0.00157069230958
Diabetes [dsyn] 0.00156455517034
Medical [ftcn] 0.00155903290221
Available [ftcn] 0.00155038622542
mmHg [qnco] 0.00153953718119
Decrease [qlco] 0.00150467002394
Range [qnco] 0.0015010537014
hypertensive [fndg] 0.00147625017228
function [phsf] 0.00147469505899
Estrogens [horm, phsu, strd] 0.00147163020615
Users [humn] 0.00145354528862
Individual [popg] 0.00144432679963
Guidelines [inpr] 0.00140853612713
Plus [qlco] 0.00140528779479
Various [irda] 0.00138546379623
Science [ocdi] 0.00138146865787
Estradiol [horm, phsu, strd] 0.00137190510892
Primary [qlco] 0.00137115100057
Endothelial [tisu] 0.00135886091181
PREVENT [phsu] 0.00135161227851
Values [qlco] 0.00134801142946
intervention [hlca] 0.00134493660823
Drugs [phsu] 0.00134006710466
coronary artery disease [dsyn] 0.00132551577982
IMPACT [gngm] 0.00132509702541
Marker [clna] 0.00131924099958
Several [qnco] 0.00130870931902
Duration [tmco] 0.00128004743839
Flow [npop] 0.00127870400141
Confidence Interval [qnco] 0.00127792249077
Hospital [hcro, mnob] 0.00127733945563
Dose [qnco] 0.00127046288283
Diet [food] 0.00126828592708
LTD [ortf] 0.00126748198444
weeks [tmco] 0.00126683488907
Association [menp] 0.00126286149703
Body Mass Index [diap] 0.00125337766945
Drug Therapy [topp] 0.00124484399271
Recent [tmco] 0.00124037614958
Combination [qlco] 0.00123940826104
Heart disease [dsyn] 0.00123320514375
Drug [phsu] 0.00121841329304
development [phsf] 0.00121761629513
Well [qlco] 0.00121669556184
Current [tmco] 0.00121498991923
High Density Lipoprotein Cholesterol [bacs, lipd] 0.00121064989055
Statins [orch, phsu] 0.00121038320251
Surgery [bmod] 0.00120752453509
Article [inpr] 0.00120508935385
Specific [qlco] 0.00118518182372
Daily [tmco] 0.00118513345225
Heart [bpoc] 0.00118063458837
cardiovascular risk factor [dsyn] 0.00118035462013
Response [orga] 0.00118020542038
Cholesterol, LDL [bacs, strd] 0.00116495882838
Comparison [acty] 0.00116491898649
Average [qnco] 0.00115920217642
Known [qlco] 0.00115531808384
Common [qnco] 0.00115525482509
Alone [qnco] 0.00114577917508
findings [ftcn] 0.00114296678501
Care [acty] 0.00114021388835
condition [dsyn] 0.00113614043446
Need [qlco] 0.00113609952794
Agent [chvf] 0.0011250264141
low [qlco] 0.00112249882123
considered [idcn] 0.0011158283702
Examined [fndg] 0.00110728853375
Complications [patf] 0.00109607003118
Transdermal [ftcn] 0.00109488434756
month [tmco] 0.00109287517868
Assessed [acty] 0.00108979157812
Provide [acty] 0.00108086736537
Concentrations [menp] 0.0010741864137
High Risk [qlco] 0.00107035482221
Diabetes Mellitus [dsyn] 0.00106088582726
Independent [idcn] 0.00104768356313
Diagnosis [fndg] 0.00104600212339
Following [tmco] 0.00104055064104
medroxyprogesterone acetate [horm, phsu, strd] 0.00103575795688
diabetic [fndg] 0.00102719986966
Reported [inpr] 0.00102501268005
Evaluated [ftcn] 0.00101831922038
Select [acty] 0.00101767500321
Odds Ratio [qnco] 0.00101584852633
progression [patf] 0.00101505909128
Information [idcn] 0.00101156097587
Predictor [idcn] 0.0010099420932
Benefits [qnco] 0.0010050425356
days [tmco] 0.00100345182722
Overall [inpr] 0.00100125016628
Mechanisms [ftcn] 0.000999624531541
vascular [bpoc] 0.00099665326285
Total Cholesterol [lbpr] 0.000988190929301
mg day [qnco] 0.000986857591596
Prevalence [qnco] 0.00098067705269
Quality [qlco] 0.000980285610873
Assess [acty] 0.000978257911273
homocysteine [aapp, bacs] 0.000977130852635
Continuous [idcn] 0.000976313329045
Elderly [popg] 0.00097577591867
Improvement [cnce] 0.000972778160558
lowering [spco] 0.000971628952678
Aged [orga] 0.000970573490386
Equal [qlco] 0.000970162076381
Evaluation [ftcn] 0.000969107325458
Large [qnco] 0.000965793148366
Often [tmco] 0.000965333393081
Equine [mamm] 0.000947898718154
History [ocdi] 0.000947213053277
Take [hlca] 0.000946027506206
Conjugated estrogen [horm, phsu, strd] 0.000941721696583
setting [ftcn] 0.000941171497495
I- [inch] 0.000938217343285
Smoking [inbe] 0.000937632870669
Make [ftcn] 0.000933307540073
Administration [ocac] 0.000928228235947
Risk factor [qnco] 0.000926613546782
Future [tmco] 0.000926470112071
Purpose [ftcn] 0.000926302293365
Clinical Trials [resa] 0.000922721751343
Increasing [ftcn] 0.000922088465933
activity [dora] 0.000916002429435
Low Density Lipoprotein Cholesterol [bacs, strd] 0.000911945370476
Endothelium [tisu] 0.000901216402725
Possible [qlco] 0.000900484811419
Statin [orch, phsu] 0.000899538176338
Null [qnco] 0.000898170695737
acute [tmco] 0.000894006338743
mediated [socb] 0.000892361535861
recommendations [idcn] 0.000891690305595
Aspirin [orch, phsu] 0.000890932983997
Exercise [dora] 0.000881320755657
Ireland [geoa] 0.000879369366261
Atrial Fibrillation [patf] 0.000879100256106
Physicians [prog] 0.000878478114311
regimens [inpr] 0.000878065266573
R- [spco] 0.00087502495719
Published [ocac] 0.000874901038658
High density lipoprotein [aapp, bacs, lipd] 0.000874539175913
Severe [qlco] 0.000862257987053
ischaemic heart disease [dsyn] 0.00085755259457
Administered [ftcn] 0.000854841246862
symptoms [ftcn] 0.000850892794785
Sclerotherapy [topp] 0.000850454520233
Life [idcn] 0.000848841118811
Main [qlco] 0.000848517927865
Favorable [qlco] 0.000848045907775
tibolone [phsu, strd] 0.000840458725927
Additional [ftcn] 0.000837519616468
Approach [spco] 0.000836606006401
Presence [topp] 0.000836339001237
Seen [qlco] 0.000836212077204
Adjusted [ftcn] 0.000819958824894
Echocardiography [diap] 0.00081808415802
radiotherapy [inpr] 0.000815198207761
Five [qnco] 0.000812096589671
Triglycerides [bacs, lipd] 0.000810815263837
In [qnco] 0.000806681187768
premenopausal [tmco] 0.000804472687192
GIVEN [cnce] 0.000803498975964
Safety [hcpp] 0.000797675923196
Insulin [aapp, horm, phsu] 0.000793305019894
Parameters [fndg] 0.00079057513231
Cohort [popg] 0.000787319097826
Initial [tmco] 0.000786888617629
Addition [ftcn] 0.000784683573999
Diseases [dsyn] 0.000780795206905
prospective [resa] 0.000779899656642
Woman [popg] 0.000779329868644
Cancer [neop] 0.000778850454301
Four [qnco] 0.00077788637808
measurements [ftcn] 0.000775783711586
Established [qlco] 0.00077411696855
Currently [tmco] 0.000769812948413
Conduct [inbe] 0.000769532223586
Report [inpr] 0.000768802708858
Affect [menp] 0.000763089267385
Literature [inpr] 0.000760425969948
Relationship [qlco] 0.000760201084606
Needed [qlco] 0.000754851925706
Strong [qlco] 0.000749403932037
Hypercholesterolaemia [dsyn] 0.000745649462613
Dependent [qlco] 0.000741801027731
Characteristics [qlco] 0.000741631266709
Single [popg] 0.000738642533458
Elevated [qlco] 0.000734642709612
Therapeutic [topp] 0.00073013766994
Interaction [ftcn] 0.000728805943721
Correlation [qlco] 0.000728424148802
national [inpr] 0.000727089568511
Lp(a) [aapp, bacs] 0.000726866322896
Obesity [dsyn] 0.000725589471918
Protection [fndg] 0.000725044347718
Compare [acty] 0.000724916395451
Progesterone [horm, phsu, strd] 0.000723744843841
mmol/L [qnco] 0.000723322838727
participants [popg] 0.000722963299997
Improved [qlco] 0.000719563601655
Complex [qlco] 0.000716648692401
Ratio [qnco] 0.000710954018493
Model [inpr] 0.000709396793533
Reducing [qlco] 0.000707824127588
Secondary Prevention [topp] 0.000706723767265
Required [ftcn] 0.000702472500992
Low density lipoprotein [aapp, bacs, lipd] 0.00069959788097
cardiovascular events [fndg] 0.000698866701753
Survival [acty] 0.000697526307446
experience [menp] 0.000697141471384
Risks [qlco] 0.000695896899566
Arterial [bpoc] 0.000695185103672
Hormone [horm] 0.000693704870256
Controlled [ftcn] 0.000692387851027
Defined [cnce] 0.000690801738239
Fasting [fndg] 0.000690552385561
Status [qlco] 0.000687184250265
Limited [ftcn] 0.000683243778557
objectives [inpr] 0.000679589202003
Help [socb] 0.000678983395683
Estrogen Replacement Therapy [topp] 0.00067733061247
Life Style [socb] 0.000677046005684
Replacement [topp] 0.000673357477607
Costs [qnco] 0.000672632815929
Value [qnco] 0.000672131677263
reviewed [inpr] 0.000669738978059
frequency [qnco] 0.000669238446319
DOUBLE BLIND [resa] 0.000668211486183
prescribed [hlca] 0.000668028868871
Same [qlco] 0.000662960719111
Sex [orgf] 0.000659968216975
HRT [topp] 0.000659732566718
therapy, hormonal [topp] 0.000657155317451
Cardiac [bpoc] 0.000655290969808
Contribute [acty] 0.000655287648734
Long [qlco] 0.000653966146613
placebo-controlled [resa] 0.00065373996059
Dyslipidaemia [dsyn] 0.000651175585885
Better [qlco] 0.000650872539492
Target [ftcn] 0.000649867184348
chronic [tmco] 0.00064846252208
APPEAR [qlco] 0.000647702383998
Relative Risk [qnco] 0.000644836065793
influential [idcn] 0.00064367897367
criteria [inpr] 0.000642901765989
Six [qnco] 0.000642490376677
Control Group [grup] 0.000641156173665
Assigned [ftcn] 0.000640743443073
Obtained [ftcn] 0.000639822107861
Post-Menopause [orgf] 0.000639632997288
Overweight [sosy] 0.000638622240312
GH [aapp, enzy] 0.00063669074253
variables [qlco] 0.000634348310639
Normal [qlco] 0.000633958702722
Lipoprotein (a) [aapp, bacs] 0.000632164309102
Morbidity [qnco] 0.000631091359165
Primary Prevention [topp] 0.000627712461715
Progestagen [horm, phsu, strd] 0.000624115158399
Link [inpr] 0.000623005479447
Last [qlco] 0.000622152998057
Onset [qlco] 0.000621493496293
practice [menp] 0.000621484699448
Likely [qlco] 0.000621452009112
Alternative [cnce] 0.00062066772043
Previous [tmco] 0.000619337171311
Intima media thickness [clna] 0.000618495532291
Children [aggp] 0.000615833161165
Fibrinogen [aapp, bacs, phsu] 0.000607438927892
Part [spco] 0.00060733952715
Goal [inpr] 0.000605670712466
Method [inpr] 0.00060450041875
Conjugated Equine Estrogens [horm, phsu, strd] 0.000601307899052
Question [inpr] 0.000598533008558
Blood [tisu] 0.000597898856598
Medication [phsu] 0.000597323976771
median [spco] 0.000595453708342
Recently [tmco] 0.000594204069943
Hormones [horm] 0.000594058693338
End [spco] 0.000588743075997
Venous malformation [anab] 0.000588436460228
choice [inbe] 0.000587273191427
Tamoxifen [orch, phsu] 0.000584486694937
investigated [ftcn] 0.00058425659592
Altered [ftcn] 0.000582875800564
Identified [qlco] 0.000581406258514
Heart failure [dsyn] 0.000579866517412
Estrogen Replacement [topp] 0.00057620324364
Test [lbpr] 0.000572776532414
Lipoprotein [aapp, bacs] 0.000569833301722
Few [qnco] 0.000568623092241
atherosclerotic [ftcn] 0.000568098090694
Congestive heart failure [dsyn] 0.000566812641972
Physical activity [dora] 0.000566696953915
Active [ftcn] 0.000566595391713
Velocity [qnco] 0.000566128173992
Dietary [food] 0.000562602532494
Represent [acty] 0.000561677104338
Cost [qnco] 0.00056024287317
H+ [elii] 0.000559909153277
Breast [bpoc] 0.00055893399527
Past [tmco] 0.000555777088838
responses [orga] 0.000555548613464
distribution [idcn] 0.000555479691119
Estimated [qnco] 0.000554629697492
Cycle [tmco] 0.000554049542291
American [popg] 0.000553826025333
Education [edac] 0.000552248009451
confirmed [qlco] 0.000549323281098
Order [inpr] 0.000547284989831
investigate [ftcn] 0.000547082842284
Coronary heart disease risk [inpr] 0.000544975456065
Occur [acty] 0.000542138153863
Relation [famg] 0.00054033754991
Little NOS [cgab, dsyn] 0.000540012903005
Class [inpr] 0.000538895317482
Play [dora] 0.000538317084294
Support [medd] 0.000537619652393
Periodontitis [dsyn] 0.00053695923036
Nitric Oxide [bacs, inch, phsu] 0.000536702336395
Inflammatory [ftcn] 0.000536244327503
mg/d [qnco] 0.000535881225992
If [qlco] 0.00053441624554
hormone replacement [topp] 0.000533091255822
Understanding [menp] 0.000532234921567
Gender [orga] 0.000531099540913
Difficult [qlco] 0.000526896192957
Lipoproteins [aapp, bacs] 0.000526677182225
Young [tmco] 0.000526291363967
Involved [ftcn] 0.000525958178628
Case [ftcn] 0.00052583047033
Relative [famg] 0.000524993647546
Appropriate [qlco] 0.000524190803297
Diagnosed [fndg] 0.000524116256371
side effects [ftcn] 0.000523733207972
Issue [fndg] 0.000523217995224
Small [qnco] 0.000522060575525
Measure [qnco] 0.000520854001729
techniques [inpr] 0.000520788298105
Percent [qnco] 0.000520541830935
Action [ftcn] 0.000520449051895
Out [spco] 0.000520104642093
interventions [hlca] 0.000519376489334
Concentration [menp] 0.000516672390435
Assessment [hlca] 0.000511949267502
twenty [orch, phsu] 0.000511843773459
Expression [topp] 0.000510247845137
Concern [idcn] 0.000510241231728
Systolic [tmco] 0.00050835582034
Direct [qlco] 0.000508200429071
Recommended [idcn] 0.000507617226684
Documented [hlca] 0.000506998945931
Abnormalities [cgab] 0.000505837913669
Prognostic Factor [clna] 0.000505432487984
???lead [elii, hops] 0.000505387365291
Damage [inpo] 0.000505300332363
Eight [qnco] 0.000505068449676
Reperfusion [topp] 0.000504816400884
With [qlco] 0.000503756173277
Pulse Pressure [orgf] 0.000500064127464
Seven [qnco] 0.000499848597133
topic5
Estrogen [horm, phsu, strd] 0.00491169446655
N NOS [aapp, imft] 0.00416600765353
placebo [topp] 0.0031913846269
mg% [qnco] 0.00298034665222
Menopause [phsf] 0.00259672273884
Blood Pressure [orgf] 0.00257491014782
Raloxifene [orch, phsu] 0.00257026352909
Oral [spco] 0.00250086426138
Myocardial Infarction [dsyn] 0.00241010788746
C-reactive protein [aapp, imft] 0.0023016441515
Decrease [qlco] 0.00224392130682
Atherosclerosis [dsyn] 0.00215225857484
Combined [qlco] 0.00213748803696
Men [popg] 0.00207845025519
Incidence [qnco] 0.00206485832692
Drug Therapy [topp] 0.00202987612151
Similar [qlco] 0.00202473688841
Subject [grup] 0.00198292446683
Old [tmco] 0.0019611140754
Plasma [bdsu] 0.00192439430106
Measured [qlco] 0.00188776359508
Non [ftcn] 0.00184884222633
randomized [resa] 0.00182869898771
coronary [bpoc] 0.00179904660699
function [phsf] 0.00176408652264
Equal [qlco] 0.00171153565781
coronary artery disease [dsyn] 0.00170900711158
Breast Cancer [neop] 0.00170464638092
PREVENT [phsu] 0.00169362474959
Total Cholesterol [lbpr] 0.00169248174265
Users [humn] 0.00166932294416
Receive [qlco] 0.00166478064675
Cholesterol [bacs, strd] 0.00164165893685
Benefit [qnco] 0.00163807353613
Decreased [qnco] 0.00162823943
Profile [lbpr] 0.00161383677186
Serum [bdsu] 0.0016055480487
Death [orgf] 0.0015801925119
development [phsf] 0.00157568825669
Estradiol [horm, phsu, strd] 0.0015755499466
Drug [phsu] 0.00157524875291
Association [menp] 0.00156188762155
Events [evnt] 0.00155763054001
Change [ftcn] 0.00155600915234
Statins [orch, phsu] 0.00155224078817
condition [dsyn] 0.00151838054956
Stroke [dsyn] 0.0014946218043
Lipid [lipd] 0.00149296560284
Take [hlca] 0.00149278358694
Alone [qnco] 0.00147489271685
Science [ocdi] 0.00146907860193
Primary [qlco] 0.00146512643037
Aged [orga] 0.00146181538872
weeks [tmco] 0.00146003743858
mmHg [qnco] 0.00145099518234
Acute myocardial infarction [dsyn] 0.00144851528186
considered [idcn] 0.00142954385049
Progestin [horm, phsu, strd] 0.00142709749737
low [qlco] 0.00142476371455
Individual [popg] 0.00137557836065
findings [ftcn] 0.00137538692002
Body Mass Index [diap] 0.00137256868783
Range [qnco] 0.00135660736455
Early [tmco] 0.00135429277584
Induced [ftcn] 0.00135273338745
Independent [idcn] 0.00135038770636
Confidence Interval [qnco] 0.00134570998283
Current [tmco] 0.00133052176915
Increasing [ftcn] 0.00131533827045
Drugs [phsu] 0.00129904382841
Assessed [acty] 0.00129335801015
Benefits [qnco] 0.00128106486431
Medical [ftcn] 0.00127930547391
Odds Ratio [qnco] 0.00127645244902
Heart disease [dsyn] 0.00126932183559
Concentrations [menp] 0.00126084873596
Provide [acty] 0.00124849290493
lowering [spco] 0.00123374632841
Guidelines [inpr] 0.00123335937308
vascular [bpoc] 0.00123259475707
Available [ftcn] 0.00123024318784
mg dl [qnco] 0.00122182254448
Response [orga] 0.00122022106415
Recent [tmco] 0.00121460397339
cardiovascular risk factor [dsyn] 0.00120954442445
Safety [hcpp] 0.00119899202179
Endothelial [tisu] 0.00119595261422
Diabetes [dsyn] 0.00117419234911
High Density Lipoprotein Cholesterol [bacs, lipd] 0.00117365944491
Elderly [popg] 0.00116166409987
Parameters [fndg] 0.00115918335613
Administration [ocac] 0.00114947024488
Dose [qnco] 0.00114418999782
Osteoporosis [dsyn] 0.00113313005454
Examined [fndg] 0.00112537121845
Equine [mamm] 0.0011155671533
tibolone [phsu, strd] 0.0011110971383
hypertensive [fndg] 0.00110361098829
Care [acty] 0.00109506559569
Relationship [qlco] 0.00109432632846
Plus [qlco] 0.0010835322711
Cases [ftcn] 0.00107292983912
Combination [qlco] 0.00107101698072
Predictor [idcn] 0.00106793540894
Assess [acty] 0.00106170511928
IMPACT [gngm] 0.00105919271177
Well [qlco] 0.00104760220089
Information [idcn] 0.00104607246057
Hospital [hcro, mnob] 0.00104387086459
acute [tmco] 0.00104368381702
Large [qnco] 0.0010382478653
Diet [food] 0.00103810072271
Low Density Lipoprotein Cholesterol [bacs, strd] 0.00102663198166
Various [irda] 0.00102472483162
Marker [clna] 0.0010158814971
Overall [inpr] 0.00101553385534
In [qnco] 0.00101044749453
Several [qnco] 0.00100794847826
Estrogen Replacement Therapy [topp] 0.00100625506787
Values [qlco] 0.00100604800146
Article [inpr] 0.00100469285771
Need [qlco] 0.00100307875155
Mechanisms [ftcn] 0.000995188761963
R- [spco] 0.000993600874174
Reported [inpr] 0.000989149666872
medroxyprogesterone acetate [horm, phsu, strd] 0.000988108611538
Morbidity [qnco] 0.00098043956798
ischaemic heart disease [dsyn] 0.000972771226804
Duration [tmco] 0.000971929605901
Following [tmco] 0.000964139159002
Dependent [qlco] 0.000963486273854
progression [patf] 0.000960765076001
Continuous [idcn] 0.000960743464651
Agent [chvf] 0.000956570154213
Flow [npop] 0.000946055309366
Estrogens [horm, phsu, strd] 0.000945806296221
diabetic [fndg] 0.000945052993236
Diagnosis [fndg] 0.000943524707733
LTD [ortf] 0.000943385175446
Likely [qlco] 0.000943023668747
Future [tmco] 0.000939162520837
Risk factor [qnco] 0.00093836877643
Diabetes Mellitus [dsyn] 0.000937144536743
Purpose [ftcn] 0.000933406231488
Risks [qlco] 0.000931129519431
symptoms [ftcn] 0.000925516779726
HRT [topp] 0.000920447812767
Initial [tmco] 0.000920439593502
Obesity [dsyn] 0.000919273054561
Conjugated estrogen [horm, phsu, strd] 0.000917624926538
Survival [acty] 0.000917323376606
I- [inch] 0.000912333562246
Evaluated [ftcn] 0.000911404284606
Often [tmco] 0.000907671347887
Cost Effectiveness [qnco] 0.000904331197058
Cancer [neop] 0.000903738098122
Smoking [inbe] 0.000901513129668
Complications [patf] 0.000898745371991
Average [qnco] 0.00089545115652
Cholesterol, LDL [bacs, strd] 0.000894705383078
mg day [qnco] 0.000893081714347
Value [qnco] 0.000887006980661
Obtained [ftcn] 0.000879246912395
Relative Risk [qnco] 0.000877708700376
Four [qnco] 0.00087753633942
Favorable [qlco] 0.000876760810859
Recently [tmco] 0.000873666528556
Specific [qlco] 0.000869973925955
Improved [qlco] 0.000868625028192
experience [menp] 0.000867666545632
Interaction [ftcn] 0.00086701233833
Report [inpr] 0.000863310310368
Ireland [geoa] 0.000860799517319
days [tmco] 0.000858676292047
Approach [spco] 0.000844518387191
Triglycerides [bacs, lipd] 0.00083622660106
influential [idcn] 0.00083144041478
High Risk [qlco] 0.000831050290212
Part [spco] 0.000830156488622
Sclerotherapy [topp] 0.000829229797507
Known [qlco] 0.000828000262934
Received [qlco] 0.000827681237667
Dyslipidaemia [dsyn] 0.000826456394281
Adjusted [ftcn] 0.000823622108988
History [ocdi] 0.000821179818867
Secondary Prevention [topp] 0.000818934078154
Long [qlco] 0.000816905247269
measurements [ftcn] 0.000816773834515
Prevalence [qnco] 0.00081677249122
Heart [bpoc] 0.000814288408837
Echocardiography [diap] 0.000812194361338
Cardiac [bpoc] 0.000808966228808
Transdermal [ftcn] 0.000808847177247
Strong [qlco] 0.000808185115671
Help [socb] 0.000807323318034
Clinical Trials [resa] 0.000805272761261
Evaluation [ftcn] 0.000804872072611
Previous [tmco] 0.000804176711503
Characteristics [qlco] 0.000803748473466
month [tmco] 0.000803003430238
Atrial Fibrillation [patf] 0.000802741236958
activity [dora] 0.000801971597874
intervention [hlca] 0.000801679593372
Make [ftcn] 0.000798559030671
Life [idcn] 0.000798267129108
Affect [menp] 0.000798199373876
Target [ftcn] 0.000798134601793
radiotherapy [inpr] 0.00079628892652
Possible [qlco] 0.000794090883673
Null [qnco] 0.000792215457959
Improvement [cnce] 0.000792157700869
Common [qnco] 0.000791293793108
Hypercholesterolaemia [dsyn] 0.000790466433236
median [spco] 0.000789220903805
Statin [orch, phsu] 0.000784442055284
Progesterone [horm, phsu, strd] 0.000784301155137
Normal [qlco] 0.000783274942607
Quality [qlco] 0.000783175948671
recommendations [idcn] 0.000782946351464
mediated [socb] 0.000781678903176
national [inpr] 0.000777123553894
Same [qlco] 0.000776563353826
Elevated [qlco] 0.000773946981162
investigated [ftcn] 0.000773419169151
cardiovascular events [fndg] 0.000773060112917
Exercise [dora] 0.000772963835142
setting [ftcn] 0.000770627821567
Ratio [qnco] 0.000768088006081
Aspirin [orch, phsu] 0.000762227512132
Presence [topp] 0.000761062189966
Damage [inpo] 0.000758669881493
homocysteine [aapp, bacs] 0.000754658439102
Normotensive [fndg] 0.000752812650318
Concern [idcn] 0.000751509198314
Established [qlco] 0.000748545086542
Daily [tmco] 0.000747553359973
Index [inpr] 0.000744738036721
Arterial [bpoc] 0.000744168505222
Fibrinogen [aapp, bacs, phsu] 0.000743246289313
Lp(a) [aapp, bacs] 0.000742177544674
APPEAR [qlco] 0.000741658673034
Recommended [idcn] 0.000740856015719
regimens [inpr] 0.000740610722403
Defined [cnce] 0.000740487032982
Contribute [acty] 0.000725058020138
Breast [bpoc] 0.000723073533088
Compliance [qnco] 0.000721875007603
Altered [ftcn] 0.000720584593167
Conduct [inbe] 0.000719144863474
Therapeutic [topp] 0.000715017669553
Controlled [ftcn] 0.000711738737603
Insulin [aapp, horm, phsu] 0.000707953828636
Play [dora] 0.000701870300778
variables [qlco] 0.000700424142259
Medication [phsu] 0.000700272171336
Published [ocac] 0.000699630093553
Systolic blood pressure [clna] 0.000699526589492
Complex [qlco] 0.000698896515449
Life Style [socb] 0.000697904645324
Systolic [tmco] 0.000697812117775
Seen [qlco] 0.000696412913932
Post-Menopause [orgf] 0.000695399277495
Concentration [menp] 0.000695352817558
premenopausal [tmco] 0.000693332681252
Status [qlco] 0.000692421618774
Estimated [qnco] 0.000690958445081
DOUBLE BLIND [resa] 0.000688017490024
Endothelium [tisu] 0.000686423460811
Cost [qnco] 0.000685542777276
Lipoproteins [aapp, bacs] 0.000682674195665
Replacement [topp] 0.000681304873933
Literature [inpr] 0.000679489922829
participants [popg] 0.000678171439499
Main [qlco] 0.000673799559901
Protection [fndg] 0.000672534554213
Addition [ftcn] 0.000670094201608
Selective Estrogen Receptor Modulators [horm, phsu] 0.000666258798841
Reducing [qlco] 0.00066469004029
Menopausal [phsf] 0.000663123583658
Tamoxifen [orch, phsu] 0.000661753542305
investigate [ftcn] 0.000659421723311
Five [qnco] 0.000659244508618
Conjugated Equine Estrogens [horm, phsu, strd] 0.000658663383573
objectives [inpr] 0.000654154466482
Required [ftcn] 0.000654129524135
Severe [qlco] 0.000651170829527
Percent [qnco] 0.000650793318057
Lipids [lipd] 0.000650752253525
Support [medd] 0.000650627335827
Woman [popg] 0.000647374382015
Additional [ftcn] 0.000645500863184
Comparison [acty] 0.000645257939726
Past [tmco] 0.000642624439473
Single [popg] 0.00064229402899
If [qlco] 0.000638623011443
Systemic [ftcn] 0.000636196634646
atherosclerotic [ftcn] 0.000636153810679
Indicated [fndg] 0.000634235018038
Administered [ftcn] 0.000633990295594
adverse effects [ftcn] 0.000632711715132
Prognostic Factor [clna] 0.000629058045556
Severity [qlco] 0.000627239662281
matched [resa] 0.000625356569677
Direct [qlco] 0.000621990661649
Currently [tmco] 0.000620739372785
Out [spco] 0.000619414351839
Cohort [popg] 0.000616945347783
GH [aapp, enzy] 0.000616611638688
High density lipoprotein [aapp, bacs, lipd] 0.000614791288505
Glucose [bacs, carb, phsu] 0.00061359489171
With [qlco] 0.000613292181579
Hormone [horm] 0.000610751251797
Low density lipoprotein [aapp, bacs, lipd] 0.000610505085909
Six [qnco] 0.00061009345519
practice [menp] 0.000609691373342
Coronary heart disease risk [inpr] 0.000609621335342
GIVEN [cnce] 0.000607379921532
Goal [inpr] 0.000607097935009
Sample [sbst] 0.000606963512039
Sex [orgf] 0.000606606668742
H+ [elii] 0.000605764896055
hormone replacement [topp] 0.000603785003579
Small [qnco] 0.00060305786278
Pulse Pressure [orgf] 0.000601640238036
Lipoprotein (a) [aapp, bacs] 0.000599712667582
Estrogen Replacement [topp] 0.000597008028078
End [spco] 0.00059637455488
Primary Prevention [topp] 0.00059441763115
Needed [qlco] 0.000593873697157
Expression [topp] 0.000593053553761
Better [qlco] 0.000590842424722
Metabolic [ftcn] 0.000589794153932
Alternative [cnce] 0.000589624771191
Involved [ftcn] 0.000586398099281
mmol/L [qnco] 0.000586122544746
Correlation [qlco] 0.000585243513879
Method [inpr] 0.000585063019351
Late [tmco] 0.000582584168058
Diastolic blood pressure [clna] 0.000582092723281
Now [tmco] 0.000581820149366
Diagnosed [fndg] 0.000581362088921
Physicians [prog] 0.000581343265906
Action [ftcn] 0.0005759740088
Intima media thickness [clna] 0.000575080153246
Assessment [hlca] 0.000572518751688
Control Group [grup] 0.000569716540166
properties [qlco] 0.00056963708032
Identified [qlco] 0.000568413940123
Coagulation [ortf] 0.000561180711656
Children [aggp] 0.000560280544404
Variability [cnce] 0.000558399039059
Screening [hlca] 0.000558398168094
Inflammation [patf] 0.00055834169485
Correlated [qlco] 0.000558309431915
Relative [famg] 0.000555131291894
Limited [ftcn] 0.000554871000559
Very [qlco] 0.000551277589809
Blood [tisu] 0.000549580030642
mg/d [qnco] 0.000548447829626
Diseases [dsyn] 0.000546932709108
Metabolic syndrome [dsyn] 0.000544411239591
Myocardial [spco] 0.000543113565526
Moderate [qlco] 0.000542656754823
heart rate [clna] 0.000540929063637
Select [acty] 0.000539716966966
Case [ftcn] 0.000537685691
Model [inpr] 0.00053660098182
Third [qnco] 0.000536165807785
confirmed [qlco] 0.000535064498874
Ii [aapp] 0.000534973587103
Onset [qlco] 0.000534627994307
Compare [acty] 0.000534240657349
Lipoprotein [aapp, bacs] 0.00053348961895
Form [qlco] 0.000531337652342
Congestive heart failure [dsyn] 0.000529072724618
Adults [aggp] 0.000528450818625
Male [fndg] 0.000528060419065
Ability [orga] 0.000527848400211
Assigned [ftcn] 0.000527272256403
lesions [fndg] 0.000525110387863
People [popg] 0.000524408267802
Heart failure [dsyn] 0.000523391926053
secondary [neop] 0.000522054880388
society [orgt] 0.000521597139999
Female [fndg] 0.000521458308208
Question [inpr] 0.000521292319867
Occurred [acty] 0.000521157337712
American [popg] 0.00052035666013
Cycle [tmco] 0.000517400796729
Natural [ftcn] 0.000516357795759
Multiple [qnco] 0.000514437619862
Measure [qnco] 0.000512421311023
Exist [cnce] 0.000510189012411
prospective [resa] 0.00050986485936
Initiate [idcn] 0.000509571886866
account [idcn] 0.000507267063947
placebo-controlled [resa] 0.000505980671034
Hormones [horm] 0.000504451185922
Radiation [npop] 0.000503946209428
Human [humn] 0.000503764438773
topic6
Estrogen [horm, phsu, strd] 0.00497785701956
N NOS [aapp, imft] 0.00492068336132
placebo [topp] 0.0037165489888
mg% [qnco] 0.00267924086755
Menopause [phsf] 0.00242187632811
Breast Cancer [neop] 0.00239692940445
Receive [qlco] 0.00237200293745
Men [popg] 0.00227989999061
Oral [spco] 0.00225426670574
C-reactive protein [aapp, imft] 0.00220115855118
Old [tmco] 0.00217446465252
Combined [qlco] 0.00216114081055
Decreased [qnco] 0.00215372327281
Raloxifene [orch, phsu] 0.0021324134764
Death [orgf] 0.0021062556791
Benefit [qnco] 0.00207352417095
Osteoporosis [dsyn] 0.00207100501969
Plasma [bdsu] 0.0020394420904
Subject [grup] 0.00198841671352
Blood Pressure [orgf] 0.00197535869707
Non [ftcn] 0.00196224318104
Diabetes [dsyn] 0.00193883599419
Lipid [lipd] 0.00192757159318
Incidence [qnco] 0.00191753896847
Cholesterol [bacs, strd] 0.00191494832515
coronary artery disease [dsyn] 0.0018821437314
Decrease [qlco] 0.00186686758777
Serum [bdsu] 0.00185993334631
Myocardial Infarction [dsyn] 0.00180759616377
Change [ftcn] 0.00175879935394
Users [humn] 0.00173867288166
Similar [qlco] 0.00172697963367
mmHg [qnco] 0.00172254061825
Profile [lbpr] 0.0016558233047
coronary [bpoc] 0.0016412530791
Events [evnt] 0.00163963810686
Atherosclerosis [dsyn] 0.00163291361755
function [phsf] 0.00163027448215
Received [qlco] 0.00160178220472
Endothelial [tisu] 0.00158657305439
Cases [ftcn] 0.00157109400914
Equal [qlco] 0.0015371919873
Science [ocdi] 0.00151542557224
Measured [qlco] 0.00150852549364
Early [tmco] 0.00148005894045
Range [qnco] 0.0014758723986
Progestin [horm, phsu, strd] 0.0014720023116
Statins [orch, phsu] 0.00147147223273
Drug Therapy [topp] 0.00146698071256
Induced [ftcn] 0.00144907087269
Flow [npop] 0.00141218992806
High Density Lipoprotein Cholesterol [bacs, lipd] 0.00139990049311
Primary [qlco] 0.00138410601329
Concentrations [menp] 0.00137649069751
Low Density Lipoprotein Cholesterol [bacs, strd] 0.00137220269422
Often [tmco] 0.00136569507751
Benefits [qnco] 0.00136261964947
Association [menp] 0.00133941388238
symptoms [ftcn] 0.00133608379194
Dose [qnco] 0.00133407416102
Plus [qlco] 0.00133090264821
Drugs [phsu] 0.00132876115305
Values [qlco] 0.00131744862223
mg dl [qnco] 0.00131249200043
PREVENT [phsu] 0.00131210540732
Recent [tmco] 0.00129890504728
Individual [popg] 0.00129256183932
Large [qnco] 0.00129112420035
Reported [inpr] 0.00128528358219
Alone [qnco] 0.00128504488844
Several [qnco] 0.00127797075149
IMPACT [gngm] 0.00126979111466
Drug [phsu] 0.00126332372232
Estrogens [horm, phsu, strd] 0.0012515307704
Estradiol [horm, phsu, strd] 0.00124908519091
Relative Risk [qnco] 0.00122881569013
Prevalence [qnco] 0.00122010613601
Surgery [bmod] 0.0012079599246
Current [tmco] 0.00119482167054
Stroke [dsyn] 0.00119362240778
Confidence Interval [qnco] 0.00119284501127
Transdermal [ftcn] 0.00118710774773
Predictor [idcn] 0.00117712009378
Equine [mamm] 0.0011618465971
randomized [resa] 0.00115879695896
LTD [ortf] 0.00115430611065
Odds Ratio [qnco] 0.00114334594886
Overall [inpr] 0.0011358040985
tibolone [phsu, strd] 0.00113388136051
Make [ftcn] 0.00113250127288
Diet [food] 0.00113152200492
Take [hlca] 0.00112437357142
Cholesterol, LDL [bacs, strd] 0.0011231921028
condition [dsyn] 0.00112232609015
Administration [ocac] 0.00111806431433
Improvement [cnce] 0.00110799795649
Aspirin [orch, phsu] 0.00110562810497
Addition [ftcn] 0.00110427657894
Response [orga] 0.00109706163968
Agent [chvf] 0.00109123037528
lowering [spco] 0.00109033877035
HRT [topp] 0.00107855173598
Triglycerides [bacs, lipd] 0.00107182671722
Aged [orga] 0.00107176050947
Acute myocardial infarction [dsyn] 0.00107023433004
Assessed [acty] 0.0010682239956
mg day [qnco] 0.00106608440655
Established [qlco] 0.0010651093844
experience [menp] 0.00106437802041
Purpose [ftcn] 0.00106214456454
weeks [tmco] 0.00106140371939
Marker [clna] 0.00105909260295
activity [dora] 0.00104998285425
setting [ftcn] 0.00104840632446
Risks [qlco] 0.00104811323004
Select [acty] 0.00104161772495
Tamoxifen [orch, phsu] 0.00103818544207
Well [qlco] 0.00103490058686
mediated [socb] 0.0010341898077
Specific [qlco] 0.00102656748636
Hypercholesterolaemia [dsyn] 0.00101744094375
participants [popg] 0.00101264473094
Daily [tmco] 0.00101255939326
Cohort [popg] 0.00101250848265
Common [qnco] 0.00100869817556
Available [ftcn] 0.00100775874797
Combination [qlco] 0.00100649810784
Guidelines [inpr] 0.00100509827317
Dependent [qlco] 0.000999361842087
Statin [orch, phsu] 0.00099284541921
Care [acty] 0.000991124263737
Known [qlco] 0.000990169096322
ischaemic heart disease [dsyn] 0.000987927994828
Cancer [neop] 0.000984838191616
Needed [qlco] 0.000984774888636
intervention [hlca] 0.000983811607265
Currently [tmco] 0.000981089174005
homocysteine [aapp, bacs] 0.000974803051563
Elderly [popg] 0.000973487885806
Life [idcn] 0.000971885650067
Quality [qlco] 0.000966496081671
Affect [menp] 0.000966227057106
Heart disease [dsyn] 0.000965207830972
Improved [qlco] 0.000958904475761
diabetic [fndg] 0.000958749115585
Following [tmco] 0.000957905851306
Total Cholesterol [lbpr] 0.000954388935417
Evaluated [ftcn] 0.000954376877498
hypertensive [fndg] 0.000947421765153
Safety [hcpp] 0.000947194637498
vascular [bpoc] 0.000944834237332
Published [ocac] 0.000944062019523
Null [qnco] 0.000942562477145
low [qlco] 0.000939934238913
Progesterone [horm, phsu, strd] 0.000939567409143
cardiovascular risk factor [dsyn] 0.000939507166331
Heart [bpoc] 0.000925232678766
considered [idcn] 0.000925103680179
findings [ftcn] 0.000923314658173
Exercise [dora] 0.000919582183461
Examined [fndg] 0.000917743126512
Presence [topp] 0.000910987177682
Increasing [ftcn] 0.000910859972974
Medical [ftcn] 0.000908929235658
High Risk [qlco] 0.000905008773037
Future [tmco] 0.000904794958502
Therapeutic [topp] 0.000904701118164
medroxyprogesterone acetate [horm, phsu, strd] 0.000903872198169
Severe [qlco] 0.000900210503986
Status [qlco] 0.000895948881448
Estrogen Replacement Therapy [topp] 0.000895380710621
Article [inpr] 0.000894687761592
Conjugated estrogen [horm, phsu, strd] 0.000893430644206
Information [idcn] 0.000892842736985
In [qnco] 0.000884447382678
Sclerotherapy [topp] 0.000882613709195
Main [qlco] 0.000873336672564
Continuous [idcn] 0.000871414394206
acute [tmco] 0.000863237999352
month [tmco] 0.000860948421448
Four [qnco] 0.000849937277301
Lipoprotein [aapp, bacs] 0.000845955641548
Possible [qlco] 0.000842420583232
Part [spco] 0.000840699697753
Likely [qlco] 0.000836534759929
Risk factor [qnco] 0.000835408930734
Hospital [hcro, mnob] 0.000835221793344
cardiovascular events [fndg] 0.000830804101274
Diseases [dsyn] 0.000825984343285
Comparison [acty] 0.000825675440509
Initial [tmco] 0.000825536125319
Independent [idcn] 0.000822214618195
Six [qnco] 0.000820801601234
Primary Prevention [topp] 0.000818594387598
prospective [resa] 0.000816047809581
Required [ftcn] 0.000815669117542
Low density lipoprotein [aapp, bacs, lipd] 0.000815032657809
Average [qnco] 0.000813981422682
days [tmco] 0.000809188764631
Secondary Prevention [topp] 0.000801838675552
Children [aggp] 0.000798525635162
matched [resa] 0.00079184052991
Hormone [horm] 0.000789951825764
Diagnosis [fndg] 0.000789334788521
Duration [tmco] 0.000787961164073
Past [tmco] 0.000787678114617
Complications [patf] 0.000785828336588
Relationship [qlco] 0.000785355904908
Approach [spco] 0.000783026518386
development [phsf] 0.000782438247241
Five [qnco] 0.000781895723328
Alternative [cnce] 0.000778861896089
progression [patf] 0.000777727511359
Same [qlco] 0.000776653629284
Strong [qlco] 0.000776011386522
Physicians [prog] 0.000775947563218
Concern [idcn] 0.000769858756112
Ireland [geoa] 0.000768853747321
Body Mass Index [diap] 0.00076736651259
investigated [ftcn] 0.000764522607998
Report [inpr] 0.000761055675174
Case [ftcn] 0.000759431521416
Obtained [ftcn] 0.000757007181543
Mechanisms [ftcn] 0.00075655005107
Administered [ftcn] 0.000751184043663
recommendations [idcn] 0.000751107906627
History [ocdi] 0.00075021467412
Active [ftcn] 0.000744290703346
Assessment [hlca] 0.000742783851697
I- [inch] 0.000742530496914
Intake [ftcn] 0.000736911406283
Need [qlco] 0.000736500285099
Identified [qlco] 0.000736017796077
Life Style [socb] 0.000729682895502
Fibrinogen [aapp, bacs, phsu] 0.000729011390632
influential [idcn] 0.000725955484775
Method [inpr] 0.000724266938822
Cost Effectiveness [qnco] 0.000723894522289
GIVEN [cnce] 0.000722333951841
Screening [hlca] 0.000720389449162
Additional [ftcn] 0.000717786628674
Assess [acty] 0.000710986201913
Characteristics [qlco] 0.000710682892973
Normotensive [fndg] 0.000709806283413
H+ [elii] 0.000708912974141
Cardiac [bpoc] 0.000708430430146
R- [spco] 0.000702898103926
APPEAR [qlco] 0.000698729518836
Contribute [acty] 0.000692989492859
Seen [qlco] 0.000691944324916
Replacement [topp] 0.000691907324422
Measure [qnco] 0.000689387695775
High density lipoprotein [aapp, bacs, lipd] 0.000688488279952
Sex [orgf] 0.000688159375957
Recently [tmco] 0.000685932177755
Normal [qlco] 0.000685160330149
Insulin [aapp, horm, phsu] 0.000685006044957
Direct [qlco] 0.000683964383156
Elevated [qlco] 0.000683869721782
Lp(a) [aapp, bacs] 0.000683726576815
practice [menp] 0.000682630462061
Percent [qnco] 0.000681735318194
adverse effects [ftcn] 0.000681234730712
objectives [inpr] 0.000680507081456
Single [popg] 0.000679516572696
Value [qnco] 0.000676049268602
Represent [acty] 0.000672367306125
Triglyceride level [lbtr] 0.000671413653644
Control Group [grup] 0.000670734899075
Morbidity [qnco] 0.000665368858655
Venous malformation [anab] 0.000663243707643
Model [inpr] 0.000661593246067
Interaction [ftcn] 0.000660880299718
Endothelium [tisu] 0.000659898913637
median [spco] 0.000658958913379
Various [irda] 0.000658552307498
Smoking [inbe] 0.00065519840042
Cycle [tmco] 0.000653935036085
Complex [qlco] 0.000653509888432
Diabetes Mellitus [dsyn] 0.000647188292588
Better [qlco] 0.000644791650546
Menopausal [phsf] 0.000640453349425
American [popg] 0.000639719810275
Provide [acty] 0.000638898680791
Issue [fndg] 0.000638397189958
radiotherapy [inpr] 0.000637378994469
Ratio [qnco] 0.000636491699452
Compare [acty] 0.000635831672671
Evaluation [ftcn] 0.000635002075467
Favorable [qlco] 0.00063289407763
Severity [qlco] 0.000631289630327
Help [socb] 0.000628652221838
Clinical Trials [resa] 0.000627128908856
investigate [ftcn] 0.000625363778326
Breast [bpoc] 0.000624655948226
Support [medd] 0.000624213308528
Target [ftcn] 0.000623548925827
Frequent [tmco] 0.000623199220302
Sample [sbst] 0.000622397570706
Damage [inpo] 0.000622050334392
Female [fndg] 0.000620562366559
Young [tmco] 0.000620060337096
mg/d [qnco] 0.000618710128056
measurements [ftcn] 0.000616987557781
Recommended [idcn] 0.000614664483326
Link [inpr] 0.000612113957229
Dyslipidaemia [dsyn] 0.000611911099991
regimens [inpr] 0.000611043772923
Area [geoa] 0.00060900257666
Limited [ftcn] 0.000608760354446
Exist [cnce] 0.000607404330609
variables [qlco] 0.000605967710569
premenopausal [tmco] 0.000602064333762
Small [qnco] 0.000600165517409
strategies [menp] 0.000599964685851
national [inpr] 0.000598997635315
society [orgt] 0.000594185890399
Eight [qnco] 0.000593715859702
Echocardiography [diap] 0.000593699552019
End [spco] 0.000592230515028
Expression [topp] 0.000590347000511
lesions [fndg] 0.0005884895108
Norethisterone acetate [horm, phsu, strd] 0.000588067351535
Survival [acty] 0.000587155352685
Form [qlco] 0.000584119922636
absence [qnco] 0.00057990780278
Atrial Fibrillation [patf] 0.00057697537054
Inflammation [patf] 0.000576972630534
Occur [acty] 0.000575703506217
Literature [inpr] 0.000574921392862
placebo-controlled [resa] 0.000574579405187
DOUBLE BLIND [resa] 0.000573546986815
Standard [qlco] 0.000573455675874
Index [inpr] 0.000569195040308
Education [edac] 0.000566576411103
Conjugated Equine Estrogens [horm, phsu, strd] 0.00056373732785
Controlled [ftcn] 0.00056373464236
Medication [phsu] 0.000562760719318
Calcium [bacs, elii, phsu] 0.000562452529027
Systolic blood pressure [clna] 0.00056174039887
Progestagen [horm, phsu, strd] 0.000560574433756
Reducing [qlco] 0.00056037496804
Goal [inpr] 0.000558236902423
Cost [qnco] 0.00055747656516
System [ftcn] 0.00055620046623
Medications [phsu] 0.000554958086248
Inflammatory [ftcn] 0.000554853731067
Haemodialysis [topp] 0.000554451919776
Pravastatin [orch, phsu] 0.000553880288988
Reperfusion [topp] 0.000553222637973
Frequently [tmco] 0.000552238141928
Coagulation [ortf] 0.000551901486308
Previous [tmco] 0.000551748609251
Play [dora] 0.00054784428901
atherosclerotic [ftcn] 0.000547724819946
Parameters [fndg] 0.000546569221597
account [idcn] 0.000545878701998
Prognostic Factor [clna] 0.000545577842704
Question [inpr] 0.000545326323258
Insulin Sensitivity [patf] 0.000544823302867
Fatal [qlco] 0.000544563882685
Intima media thickness [clna] 0.000544203403596
responses [orga] 0.000541021409054
Correlation [qlco] 0.000540258082914
frequency [qnco] 0.00054011507434
Treatments [topp] 0.000540075550272
mmol/L [qnco] 0.000539933340363
Lipoprotein (a) [aapp, bacs] 0.000538628207974
If [qlco] 0.000537048088649
reductions [npop] 0.00053309732039
Observational Study [resa] 0.000532120473064
Radiation [npop] 0.000531919171501
Last [qlco] 0.000531540625214
Provided [acty] 0.000530451407354
Multiple [qnco] 0.000530442747733
Concentration [menp] 0.000527744019314
Compliance [qnco] 0.000527331126662
Brachial Artery [bpoc] 0.000526132587567
Systolic [tmco] 0.000525844012241
Hormones [horm] 0.000523729343961
Male [fndg] 0.000523498302155
Protection [fndg] 0.00052345321066
Low dose [qnco] 0.000522829829722
Blood [tisu] 0.000522686291277
Estrogen Replacement [topp] 0.000522174449695
Central [spco] 0.000520857956337
Arterial [bpoc] 0.0005203318401
Identification [menp] 0.000518847197152
Appropriate [qlco] 0.000517541052127
Altered [ftcn] 0.000517130953848
chronic [tmco] 0.000516544028053
???lead [elii, hops] 0.000514901506611
Post-Menopause [orgf] 0.000514657499308
Complete [qlco] 0.000510572011161
Occurred [acty] 0.000508719974156
Natural [ftcn] 0.000508570851653
Heart failure [dsyn] 0.000508048010463
Pulse Pressure [orgf] 0.000506210863436
Few [qnco] 0.000506111844965
Conduct [inbe] 0.000505782491391
topic7
Estrogen [horm, phsu, strd] 0.00511569437131
Men [popg] 0.00344948465161
placebo [topp] 0.0032233602534
N NOS [aapp, imft] 0.00301791980109
Atherosclerosis [dsyn] 0.00263405808194
Menopause [phsf] 0.00240943984121
randomized [resa] 0.00240377067773
Combined [qlco] 0.00230924535776
Plasma [bdsu] 0.00230035565979
Decreased [qnco] 0.0022817816649
Incidence [qnco] 0.00225834560967
Cholesterol [bacs, strd] 0.00225624910035
Lipid [lipd] 0.00219049398011
Range [qnco] 0.00217892215485
Receive [qlco] 0.00210704245322
Blood Pressure [orgf] 0.00207078409228
C-reactive protein [aapp, imft] 0.00204345363847
Similar [qlco] 0.00200828411466
Decrease [qlco] 0.0019965596825
Change [ftcn] 0.00197635657864
Oral [spco] 0.0019698663367
mg% [qnco] 0.00187695387786
Old [tmco] 0.00187631345919
Diabetes [dsyn] 0.00180494445389
Received [qlco] 0.00180350836838
Osteoporosis [dsyn] 0.00174400941832
Profile [lbpr] 0.00172776673304
Drug [phsu] 0.00171275186789
Death [orgf] 0.00171253904338
Non [ftcn] 0.00171237799017
Early [tmco] 0.00169910687234
HRT [topp] 0.00168281731294
Benefits [qnco] 0.00167745739586
Raloxifene [orch, phsu] 0.00166755433582
Subject [grup] 0.00166631795493
Serum [bdsu] 0.0016415532353
Primary [qlco] 0.00159410115185
Benefit [qnco] 0.00157964488502
Progestin [horm, phsu, strd] 0.00155862393093
Breast Cancer [neop] 0.00153773540571
coronary artery disease [dsyn] 0.00152749284153
Myocardial Infarction [dsyn] 0.00149019363265
Acute myocardial infarction [dsyn] 0.00148834621321
Association [menp] 0.00148719737345
function [phsf] 0.00148321832385
Dose [qnco] 0.00147561780685
Common [qnco] 0.00147254929964
coronary [bpoc] 0.00144497925854
Alone [qnco] 0.0014410162247
Events [evnt] 0.00143544789197
mg dl [qnco] 0.00143236170387
Care [acty] 0.001429553838
Science [ocdi] 0.00139367895608
Drugs [phsu] 0.00139032297734
High Density Lipoprotein Cholesterol [bacs, lipd] 0.00137582061014
Measured [qlco] 0.00136265252909
weeks [tmco] 0.0013472010271
Users [humn] 0.00134129277243
Recent [tmco] 0.00133108649076
Combination [qlco] 0.00131442881168
mmHg [qnco] 0.00130418436364
Plus [qlco] 0.00129166181295
Induced [ftcn] 0.00128368236657
Estrogens [horm, phsu, strd] 0.00127172587235
Administration [ocac] 0.00126841150305
Improvement [cnce] 0.00126420194777
Estradiol [horm, phsu, strd] 0.00125983775679
Cases [ftcn] 0.00124756684246
Current [tmco] 0.00124196429336
Reported [inpr] 0.00124145994237
Estrogen Replacement Therapy [topp] 0.00122328400939
lowering [spco] 0.00121171183475
Confidence Interval [qnco] 0.00120928921005
Therapeutic [topp] 0.00120117679546
Well [qlco] 0.00119689955048
Drug Therapy [topp] 0.00119502872833
Individual [popg] 0.00119158829933
Medical [ftcn] 0.00119054989732
progression [patf] 0.00117465593646
I- [inch] 0.0011736541411
Assessed [acty] 0.00116367601773
Stroke [dsyn] 0.00115750684296
Available [ftcn] 0.00115569309582
Values [qlco] 0.00115542467809
Endothelial [tisu] 0.0011510342248
Odds Ratio [qnco] 0.00114840682553
Marker [clna] 0.00113475026081
Equal [qlco] 0.00113395336944
Dyslipidaemia [dsyn] 0.00113244853425
Statins [orch, phsu] 0.00113238221666
Assess [acty] 0.00112873595665
Duration [tmco] 0.00112828732024
IMPACT [gngm] 0.00112658811596
Take [hlca] 0.00112256490472
Diet [food] 0.00112160558808
Cholesterol, LDL [bacs, strd] 0.00111856451397
Overall [inpr] 0.00111586509142
setting [ftcn] 0.00111236476841
Purpose [ftcn] 0.00111010161669
Several [qnco] 0.00110988106764
Response [orga] 0.00110820903818
Prevalence [qnco] 0.0011046392794
low [qlco] 0.0011021943929
Ratio [qnco] 0.00109916738051
APPEAR [qlco] 0.00109864667531
Provide [acty] 0.00109630566758
Specific [qlco] 0.00109236067584
Aged [orga] 0.00108421096531
Guidelines [inpr] 0.00108349249848
Need [qlco] 0.00108319852255
Independent [idcn] 0.00107806821155
Null [qnco] 0.00107682761784
Clinical Trials [resa] 0.00107619984788
Risks [qlco] 0.00107330647223
Elderly [popg] 0.00106030931851
High Risk [qlco] 0.00105341446815
Body Mass Index [diap] 0.00105149570372
hypertensive [fndg] 0.00104948933213
Mechanisms [ftcn] 0.0010450290852
Make [ftcn] 0.00104334985695
vascular [bpoc] 0.00104308050743
Information [idcn] 0.00102263305645
Predictor [idcn] 0.00101016289288
LTD [ortf] 0.00100958583268
Heart disease [dsyn] 0.00100515493975
Quality [qlco] 0.00100396734903
Obesity [dsyn] 0.000998810229152
Possible [qlco] 0.000993795164253
Secondary Prevention [topp] 0.00099223113167
Average [qnco] 0.000990378614207
Various [irda] 0.000987228774908
Presence [topp] 0.000982425281179
Surgery [bmod] 0.000977574142419
intervention [hlca] 0.000976790705566
Concentrations [menp] 0.000972742635994
Dependent [qlco] 0.000968819618374
Low Density Lipoprotein Cholesterol [bacs, strd] 0.000962807902588
Conduct [inbe] 0.000959848535882
cardiovascular events [fndg] 0.000959250710178
homocysteine [aapp, bacs] 0.000956181586264
Reducing [qlco] 0.000956120347578
Sclerotherapy [topp] 0.000952770101751
PREVENT [phsu] 0.000952634916908
development [phsf] 0.00095223737908
Following [tmco] 0.000952178393492
Triglycerides [bacs, lipd] 0.000949743019851
Total Cholesterol [lbpr] 0.00094528581697
Transdermal [ftcn] 0.000940287355265
Flow [npop] 0.000940276715886
Relative Risk [qnco] 0.000939981028514
Select [acty] 0.000938819302206
findings [ftcn] 0.000935699693149
Article [inpr] 0.000933867233898
Daily [tmco] 0.000930580808252
Often [tmco] 0.000926741520805
considered [idcn] 0.000925843228139
Initial [tmco] 0.000923250657011
symptoms [ftcn] 0.00092125488463
Affect [menp] 0.000916605615623
Established [qlco] 0.000911561693739
Exercise [dora] 0.000907399722201
Echocardiography [diap] 0.000905615021063
Comparison [acty] 0.000903796318275
Hospital [hcro, mnob] 0.0009019273709
R- [spco] 0.000900193174524
Relationship [qlco] 0.000890543633585
Conjugated estrogen [horm, phsu, strd] 0.000886066116205
Known [qlco] 0.000885054068962
Assessment [hlca] 0.000881552101862
In [qnco] 0.000874408325364
Cancer [neop] 0.000871740808773
Addition [ftcn] 0.000870026726182
Likely [qlco] 0.000868935615881
ischaemic heart disease [dsyn] 0.00086763118768
Insulin [aapp, horm, phsu] 0.000866714688727
Endothelium [tisu] 0.000866682206645
Survival [acty] 0.000860925131556
Aspirin [orch, phsu] 0.000859056746692
Examined [fndg] 0.000855396957316
mg day [qnco] 0.000852457543079
Complications [patf] 0.000850516535731
condition [dsyn] 0.000848668040397
Compare [acty] 0.000845277706347
Equine [mamm] 0.000839185942266
Fibrinogen [aapp, bacs, phsu] 0.00083834773652
Obtained [ftcn] 0.000832316918874
Atrial Fibrillation [patf] 0.000831580211373
DOUBLE BLIND [resa] 0.000830995442734
Large [qnco] 0.000830544797746
Approach [spco] 0.00082949214003
Future [tmco] 0.000828766691739
Improved [qlco] 0.000828224816047
month [tmco] 0.000825501115881
Diabetes Mellitus [dsyn] 0.000825199427695
cardiovascular risk factor [dsyn] 0.000822964760048
Part [spco] 0.000822308292501
Main [qlco] 0.000822098722433
Parameters [fndg] 0.000822001826731
Primary Prevention [topp] 0.000820956942304
Natural [ftcn] 0.000820893531226
acute [tmco] 0.000816495710327
Previous [tmco] 0.000816479345818
Help [socb] 0.000813257657134
medroxyprogesterone acetate [horm, phsu, strd] 0.000811742289814
Status [qlco] 0.000811443647076
Medication [phsu] 0.000810614604626
Tamoxifen [orch, phsu] 0.000807244901184
Evaluated [ftcn] 0.000806300220718
Favorable [qlco] 0.000805960206656
Statin [orch, phsu] 0.000804826318507
diabetic [fndg] 0.000797321712516
tibolone [phsu, strd] 0.000794357709857
Low density lipoprotein [aapp, bacs, lipd] 0.000786864674363
mediated [socb] 0.000786582803048
recommendations [idcn] 0.000785882727125
Agent [chvf] 0.000784030864983
activity [dora] 0.000782991541489
Four [qnco] 0.000779967830206
experience [menp] 0.000778986858809
practice [menp] 0.000778371264397
Published [ocac] 0.000776055357283
Strong [qlco] 0.000774640784224
Hormones [horm] 0.000769103059523
Estrogen Replacement [topp] 0.000768747065295
Cardiac [bpoc] 0.000764180620472
Same [qlco] 0.000762537378485
Cost Effectiveness [qnco] 0.000761835804409
regimens [inpr] 0.000759848326962
Required [ftcn] 0.000759039550306
Smoking [inbe] 0.000757334422748
Elevated [qlco] 0.000754189921891
Heart [bpoc] 0.000744761315973
days [tmco] 0.000740741725584
Alternative [cnce] 0.000739394925661
Single [popg] 0.000732133295752
influential [idcn] 0.000729946218632
Life [idcn] 0.000729627538994
Better [qlco] 0.000729342639887
Index [inpr] 0.000725743473282
Increasing [ftcn] 0.000722526159513
Value [qnco] 0.000717154080196
Complex [qlco] 0.000716076511551
Severe [qlco] 0.000715495100112
Continuous [idcn] 0.000709020818733
investigate [ftcn] 0.000708255155558
Morbidity [qnco] 0.000705410064227
Progesterone [horm, phsu, strd] 0.00070086256545
Additional [ftcn] 0.000698508675069
Diagnosis [fndg] 0.000696457401105
Woman [popg] 0.000694171096665
Currently [tmco] 0.000693495740583
Sex [orgf] 0.000692647166331
History [ocdi] 0.000691669531368
Adjusted [ftcn] 0.00069159740337
Area [geoa] 0.000689180270433
Contribute [acty] 0.00068611745595
Question [inpr] 0.000683416374218
participants [popg] 0.000683043089044
Arterial [bpoc] 0.00068207433681
Direct [qlco] 0.000680816712922
Lp(a) [aapp, bacs] 0.000680141840035
radiotherapy [inpr] 0.000675147611995
side effects [ftcn] 0.000673656827799
Progestagen [horm, phsu, strd] 0.000673387743307
Pulse Pressure [orgf] 0.000672937473692
GIVEN [cnce] 0.000671579935735
Out [spco] 0.000671052115508
Overweight [sosy] 0.000669914772656
mmol/L [qnco] 0.000667216233002
Literature [inpr] 0.000665265850285
measurements [ftcn] 0.000664606416816
Inflammation [patf] 0.000664351218085
Ireland [geoa] 0.00066345331385
If [qlco] 0.000663000829064
Support [medd] 0.000660391743181
Identified [qlco] 0.000658224529101
Observational Study [resa] 0.000655742735253
Controlled [ftcn] 0.000655243379953
Correlated [qlco] 0.000654131755463
variables [qlco] 0.000652942377476
Seen [qlco] 0.000652579320978
Diseases [dsyn] 0.000650231996925
Multiple [qnco] 0.000647482737634
Assigned [ftcn] 0.000646643190631
peripheral arterial disease [dsyn] 0.000641567099022
Cost [qnco] 0.000640975802635
Replacement [topp] 0.000640662042601
Altered [ftcn] 0.000637677139515
Intake [ftcn] 0.000637577537409
Long [qlco] 0.000636605281132
median [spco] 0.000635174644055
Fasting [fndg] 0.000631186483664
Cohort [popg] 0.000628535568257
frequency [qnco] 0.000625895808379
Play [dora] 0.000625547739998
Myocardial [spco] 0.000625258934717
Intima media thickness [clna] 0.000625013692072
Appropriate [qlco] 0.000623297814054
Report [inpr] 0.000621046244359
Interaction [ftcn] 0.000620792559715
Breast [bpoc] 0.000617323044368
Administered [ftcn] 0.000616830595343
Characteristics [qlco] 0.000616654632913
Recently [tmco] 0.000616205689561
national [inpr] 0.000615564939765
reviewed [inpr] 0.000615211561672
Systolic [tmco] 0.000614421275174
Congestive heart failure [dsyn] 0.00061382582408
Small [qnco] 0.000612095377274
H+ [elii] 0.000611886157721
Metabolic [ftcn] 0.000611284791828
Six [qnco] 0.00060624365681
Young [tmco] 0.000605203710989
Hypercholesterolaemia [dsyn] 0.000601034150314
Dietary [food] 0.000598140476355
Issue [fndg] 0.000597794846745
choice [inbe] 0.000597791991299
adverse effects [ftcn] 0.000597020317246
Occurred [acty] 0.000596013869505
Correlation [qlco] 0.000595445063205
Identification [menp] 0.000593298882496
Effectiveness [qlco] 0.000593227387659
Compliance [qnco] 0.000593177765223
Coronary heart disease risk [inpr] 0.000593086373581
Onset [qlco] 0.000590329145116
Lipoproteins [aapp, bacs] 0.000588932280039
Negative [qlco] 0.000587698379913
Prognostic Factor [clna] 0.000585497262843
Ii [aapp] 0.000584369513937
Selective Estrogen Receptor Modulators [horm, phsu] 0.000584099405764
Pravastatin [orch, phsu] 0.000583751444354
Calcium [bacs, elii, phsu] 0.000581618924319
Physicians [prog] 0.000581575437699
Safety [hcpp] 0.000581480448405
Severity [qlco] 0.000580930714075
Now [tmco] 0.000579941094733
Lipoprotein [aapp, bacs] 0.000579245370321
atherosclerotic [ftcn] 0.000577325121151
Late [tmco] 0.000575460865414
Glucose [bacs, carb, phsu] 0.000573233526987
premenopausal [tmco] 0.000571307235045
Adjustment [inbe] 0.000569448350543
With [qlco] 0.000568851926002
strategies [menp] 0.00056880168045
Recommended [idcn] 0.000568471123601
Menopausal [phsf] 0.000565425260636
prospective [resa] 0.000565010261624
Treatments [topp] 0.000563716534393
admission [hlca] 0.000563217928298
hormone replacement [topp] 0.000561478499798
Coagulation [ortf] 0.000560804839435
Target [ftcn] 0.000559678900543
rats [mamm] 0.000559446147878
Children [aggp] 0.000557257975584
Heart failure [dsyn] 0.000556900545776
responses [orga] 0.000556757069774
Five [qnco] 0.000556601748865
Evaluation [ftcn] 0.000556194691108
Simvastatin [orch, phsu] 0.000556084459734
Indicated [fndg] 0.00055557674588
investigated [ftcn] 0.000554336520387
Mechanism [ftcn] 0.000553105221235
reductions [npop] 0.000551549049516
Damage [inpo] 0.000550803483647
Past [tmco] 0.000550643520726
Very [qlco] 0.000550397187335
American [popg] 0.000548144939394
Class [inpr] 0.000545224088144
Measure [qnco] 0.00054522306105
Address [inpr] 0.000544962753479
Loss [qnco] 0.000541810380823
mg/d [qnco] 0.000538709992776
Frequently [tmco] 0.000538300620756
System [ftcn] 0.000535301752296
Nitric Oxide [bacs, inch, phsu] 0.000535218609209
objectives [inpr] 0.00053520090489
Containing [ftcn] 0.000530779339036
criteria [inpr] 0.000529898730945
Percent [qnco] 0.000529604730774
Concentration [menp] 0.000528277081776
People [popg] 0.000527584939409
Circulating [ftcn] 0.000527569516202
Model [inpr] 0.000526872680904
Progestins [horm, phsu, strd] 0.000525168063568
Standard [qlco] 0.000524802699621
Process [bpoc] 0.000524285158212
society [orgt] 0.000524217853964
Link [inpr] 0.000523053297768
interventions [hlca] 0.000521649597676
Inflammatory [ftcn] 0.000521395529059
Low dose [qnco] 0.000519987816573
Needed [qlco] 0.000519585297326
Lipid-lowering therapy [topp] 0.00051463584732
Optimal [qlco] 0.000514014618488
Modification [ftcn] 0.000513366559428
Blood [tisu] 0.000512915267224
Control Group [grup] 0.00051254588167
Hormone [horm] 0.000512472900785
Lipoprotein (a) [aapp, bacs] 0.000509724592903
Life Style [socb] 0.000509614695079
topic8
Estrogen [horm, phsu, strd] 0.00460711933845
N NOS [aapp, imft] 0.0037643083082
Men [popg] 0.0024571659104
mg% [qnco] 0.00239470156004
Oral [spco] 0.00238853150462
Decreased [qnco] 0.00234360363002
Lipid [lipd] 0.00231591786793
Menopause [phsf] 0.00231401995876
Receive [qlco] 0.00226402507953
Osteoporosis [dsyn] 0.00225965845301
placebo [topp] 0.0022300802233
Old [tmco] 0.00217524552535
Combined [qlco] 0.00216055880367
C-reactive protein [aapp, imft] 0.00212959865022
Drugs [phsu] 0.0021100442419
Acute myocardial infarction [dsyn] 0.00207558791641
coronary [bpoc] 0.00203671591751
High Density Lipoprotein Cholesterol [bacs, lipd] 0.0020324458235
Non [ftcn] 0.00198916892629
Blood Pressure [orgf] 0.00192705850131
Plasma [bdsu] 0.00192687178109
Subject [grup] 0.00192483198061
Measured [qlco] 0.00189857878212
Raloxifene [orch, phsu] 0.00187672132471
Decrease [qlco] 0.00187389744739
Users [humn] 0.00186590176007
Incidence [qnco] 0.0018380574325
Breast Cancer [neop] 0.00183359863703
Cases [ftcn] 0.00177839041773
Death [orgf] 0.00174907282521
Drug Therapy [topp] 0.00173396323223
Myocardial Infarction [dsyn] 0.00171640376619
Drug [phsu] 0.0016794756843
Alone [qnco] 0.00166572754853
Association [menp] 0.00164024834831
randomized [resa] 0.00161536787812
Events [evnt] 0.00161379524273
Profile [lbpr] 0.00160707151413
Dose [qnco] 0.00157514334807
Range [qnco] 0.00155668347816
Statins [orch, phsu] 0.00152010734104
Information [idcn] 0.00151664027208
Early [tmco] 0.00151480611976
Estradiol [horm, phsu, strd] 0.0014646354349
Diabetes [dsyn] 0.00146133929813
Progestin [horm, phsu, strd] 0.00145949358135
Change [ftcn] 0.00143666287033
Atherosclerosis [dsyn] 0.00143385945925
weeks [tmco] 0.00143355252923
Stroke [dsyn] 0.00142448315428
HRT [topp] 0.00142227135835
mmHg [qnco] 0.00141584191323
Benefit [qnco] 0.00141072948917
mg dl [qnco] 0.00140526045031
Received [qlco] 0.00140010024654
Science [ocdi] 0.00139104240754
hypertensive [fndg] 0.00138701205853
Prevalence [qnco] 0.00135891881839
Several [qnco] 0.0013573096618
coronary artery disease [dsyn] 0.00135698641166
Benefits [qnco] 0.00135446362275
Duration [tmco] 0.00133981266073
Similar [qlco] 0.00133795819355
Cholesterol [bacs, strd] 0.00133734963306
Well [qlco] 0.00132395251487
Provide [acty] 0.0013108915639
Heart disease [dsyn] 0.00130137569075
Surgery [bmod] 0.00129537777229
Various [irda] 0.00129175439513
considered [idcn] 0.00128070715138
Assess [acty] 0.00127569947711
Evaluated [ftcn] 0.00127089769316
Endothelial [tisu] 0.00126977788176
Specific [qlco] 0.00126625265625
Available [ftcn] 0.00126543858937
Total Cholesterol [lbpr] 0.00124891481306
Addition [ftcn] 0.00124739218995
setting [ftcn] 0.00124364718974
Reported [inpr] 0.00124348028209
PREVENT [phsu] 0.00124141231977
Secondary Prevention [topp] 0.00124109980447
Predictor [idcn] 0.00123087818635
Confidence Interval [qnco] 0.0012067581594
Combination [qlco] 0.00120582892257
Plus [qlco] 0.00120201652612
Values [qlco] 0.00120048726554
High Risk [qlco] 0.00120033400596
Assessed [acty] 0.00118899460562
Administration [ocac] 0.00118518115273
Marker [clna] 0.00117018226103
Make [ftcn] 0.00116978883183
lowering [spco] 0.00116166753356
APPEAR [qlco] 0.00116035835607
Individual [popg] 0.00115965887082
Current [tmco] 0.00115765516342
vascular [bpoc] 0.00115545284851
Equal [qlco] 0.00115078473238
Flow [npop] 0.00114602809487
Large [qnco] 0.00114419003758
Recent [tmco] 0.00114401519275
function [phsf] 0.00114334677197
LTD [ortf] 0.00114090696114
Body Mass Index [diap] 0.00113252926277
Likely [qlco] 0.00112476228973
Equine [mamm] 0.00111877921592
Serum [bdsu] 0.00111337797677
Concentrations [menp] 0.0011133497725
Induced [ftcn] 0.0011125934293
low [qlco] 0.00110916309558
Affect [menp] 0.00110514365444
Purpose [ftcn] 0.001103764989
Comparison [acty] 0.00110360121678
R- [spco] 0.00110100634769
Cancer [neop] 0.00109638531483
cardiovascular risk factor [dsyn] 0.00108809926943
Statin [orch, phsu] 0.00108596442498
Guidelines [inpr] 0.00108465572923
Primary [qlco] 0.0010834220494
Estrogens [horm, phsu, strd] 0.00108290874713
Clinical Trials [resa] 0.00108160779849
Examined [fndg] 0.0010811944575
Daily [tmco] 0.00107944920475
medroxyprogesterone acetate [horm, phsu, strd] 0.00107857682536
Common [qnco] 0.00107681752391
ischaemic heart disease [dsyn] 0.0010765485189
Odds Ratio [qnco] 0.00107490495077
progression [patf] 0.00106924544096
Overall [inpr] 0.00106797977935
condition [dsyn] 0.00106546491021
symptoms [ftcn] 0.00105794907437
Hospital [hcro, mnob] 0.00104819776825
development [phsf] 0.00103692256622
IMPACT [gngm] 0.00102176305833
Elderly [popg] 0.0010203002647
findings [ftcn] 0.00101774675784
Continuous [idcn] 0.00101699241283
Future [tmco] 0.00101641416621
Diet [food] 0.00101610620315
days [tmco] 0.00101548621274
Known [qlco] 0.00101228841996
Independent [idcn] 0.00100564247324
intervention [hlca] 0.000996774163763
Agent [chvf] 0.000991488146416
Aged [orga] 0.000990200423966
Care [acty] 0.000987665090761
Ireland [geoa] 0.000978950165552
Exercise [dora] 0.000978884817004
Presence [topp] 0.000974541908105
Estrogen Replacement Therapy [topp] 0.000969954261119
Conjugated estrogen [horm, phsu, strd] 0.000964072645733
Medical [ftcn] 0.000959683368535
Low Density Lipoprotein Cholesterol [bacs, strd] 0.000953562908729
Following [tmco] 0.000948760258118
Take [hlca] 0.000942205963693
Status [qlco] 0.000934446668647
Protection [fndg] 0.000933597792763
participants [popg] 0.000932976896487
Increasing [ftcn] 0.000931577830466
Article [inpr] 0.000928194281325
Null [qnco] 0.000927547480822
Hypercholesterolaemia [dsyn] 0.00092469702508
mediated [socb] 0.000923626298629
tibolone [phsu, strd] 0.000921918159844
acute [tmco] 0.000918136904142
homocysteine [aapp, bacs] 0.000912302937571
Improvement [cnce] 0.000907347135807
Select [acty] 0.000906980536942
influential [idcn] 0.000906332930063
Six [qnco] 0.000902491572535
Four [qnco] 0.000897839138325
Published [ocac] 0.000897267293273
Relationship [qlco] 0.000896939498508
Smoking [inbe] 0.00089656290449
Quality [qlco] 0.000896350916541
Mechanisms [ftcn] 0.000895548499622
activity [dora] 0.000890618188903
diabetic [fndg] 0.00088684863658
Triglycerides [bacs, lipd] 0.000881776351262
Diabetes Mellitus [dsyn] 0.000870102720162
Sex [orgf] 0.000868773028834
Therapeutic [topp] 0.000860779928549
Improved [qlco] 0.00084968171718
Aspirin [orch, phsu] 0.000840068217354
Average [qnco] 0.000838387418156
Complications [patf] 0.000836284192161
objectives [inpr] 0.000833470967181
Response [orga] 0.000829167121379
Diagnosis [fndg] 0.000825975116769
Main [qlco] 0.000816536058743
practice [menp] 0.000814673431892
Ratio [qnco] 0.000813597084078
Tamoxifen [orch, phsu] 0.000812344440683
Transdermal [ftcn] 0.00081207618899
Cohort [popg] 0.000805605535991
Risks [qlco] 0.000804004120868
mg day [qnco] 0.00080392429135
Heart [bpoc] 0.000802957924291
median [spco] 0.000802690339386
Primary Prevention [topp] 0.000801675856866
Occur [acty] 0.000800893385371
Seen [qlco] 0.000800123751248
Survival [acty] 0.000797928213471
Severe [qlco] 0.000796239470071
Additional [ftcn] 0.000796049350786
Cardiac [bpoc] 0.000795776518166
I- [inch] 0.000792882601655
Needed [qlco] 0.00079279251846
Sclerotherapy [topp] 0.000790590519268
national [inpr] 0.000790481954936
Replacement [topp] 0.000790446450638
Recommended [idcn] 0.000790386936418
Dependent [qlco] 0.000790356805113
Adjusted [ftcn] 0.000784401778732
Cost Effectiveness [qnco] 0.000782177026037
Characteristics [qlco] 0.000777100950285
premenopausal [tmco] 0.000774234081667
Need [qlco] 0.000770080737938
Reducing [qlco] 0.000766942088788
Life [idcn] 0.000765803688836
Parameters [fndg] 0.000764600608893
Assessment [hlca] 0.000763568782967
Dyslipidaemia [dsyn] 0.000762200411086
Obtained [ftcn] 0.000759362861329
Currently [tmco] 0.000758029306424
cardiovascular events [fndg] 0.000752854663709
Administered [ftcn] 0.000748283999425
Index [inpr] 0.00074783083623
In [qnco] 0.000744685398369
Low density lipoprotein [aapp, bacs, lipd] 0.000740615421098
Controlled [ftcn] 0.000737766865428
radiotherapy [inpr] 0.00073659330798
Single [popg] 0.000735416532478
GIVEN [cnce] 0.000734741746101
Heart failure [dsyn] 0.000732083597672
Damage [inpo] 0.000731326361576
Often [tmco] 0.000730508129975
Initial [tmco] 0.000727664296801
DOUBLE BLIND [resa] 0.000723840039772
Safety [hcpp] 0.000721513896285
investigated [ftcn] 0.000719245877763
Possible [qlco] 0.000710172093913
atherosclerotic [ftcn] 0.000706596331803
experience [menp] 0.000705318648583
Morbidity [qnco] 0.000703860638382
Cost [qnco] 0.000701092845367
Late [tmco] 0.000700395191939
Elevated [qlco] 0.000699431085374
Value [qnco] 0.000697050397936
month [tmco] 0.000696153910317
Insulin [aapp, horm, phsu] 0.000690711079747
Approach [spco] 0.000688800747714
Help [socb] 0.000686165420559
Normal [qlco] 0.000682998735956
Same [qlco] 0.000681177507442
Model [inpr] 0.000680558605627
Cholesterol, LDL [bacs, strd] 0.00067970465105
If [qlco] 0.00067893750187
Report [inpr] 0.000677594905237
Required [ftcn] 0.000676627903869
Direct [qlco] 0.000676195201524
Fibrinogen [aapp, bacs, phsu] 0.000675441772911
investigate [ftcn] 0.00067361895703
Compare [acty] 0.000671640482904
Radiation [npop] 0.000670504129456
Control Group [grup] 0.000665104592533
Atrial Fibrillation [patf] 0.000664818477685
Previous [tmco] 0.000664804439156
Young [tmco] 0.000664185424232
regimens [inpr] 0.000662643069481
Five [qnco] 0.000661841103425
System [ftcn] 0.000659363678578
Relative Risk [qnco] 0.000655657974842
Progestagen [horm, phsu, strd] 0.000655283693989
Cycle [tmco] 0.00065483933628
Blood [tisu] 0.000654524833539
prescribed [hlca] 0.000654376518443
Obesity [dsyn] 0.000654023357117
Congestive heart failure [dsyn] 0.000651825187962
Part [spco] 0.000651502444403
Systolic [tmco] 0.00065074032638
variables [qlco] 0.000649247038601
Established [qlco] 0.000648572476103
Dietary [food] 0.00064703198958
Favorable [qlco] 0.00064429762392
Severity [qlco] 0.000643725368561
Progesterone [horm, phsu, strd] 0.00064341308899
recommendations [idcn] 0.000642836106803
Lipoprotein [aapp, bacs] 0.000639899210005
Breast [bpoc] 0.000639363425229
Question [inpr] 0.00063820334038
matched [resa] 0.000637563033034
Triglyceride level [lbtr] 0.00063699311829
peripheral arterial disease [dsyn] 0.000635629964706
Life Style [socb] 0.000635550755475
Strong [qlco] 0.000635235098709
Better [qlco] 0.000635011596704
Percent [qnco] 0.000633994925842
American [popg] 0.000633739289536
Concern [idcn] 0.000631936904141
Target [ftcn] 0.000631010276886
Indicated [fndg] 0.000626207016691
Physicians [prog] 0.000625827922226
Systolic blood pressure [clna] 0.000625648746013
Identified [qlco] 0.000625448168913
Arterial [bpoc] 0.000620801370505
account [idcn] 0.000618412864536
side effects [ftcn] 0.0006182609711
Endothelium [tisu] 0.000617420993662
End [spco] 0.000614891610012
Past [tmco] 0.000612061164212
Measure [qnco] 0.000608694930559
Estimated [qnco] 0.000606091346236
Fasting [fndg] 0.000600666780135
Diseases [dsyn] 0.00059837634251
Conduct [inbe] 0.000597176130118
Onset [qlco] 0.000595214496002
Support [medd] 0.000594300915535
Area [geoa] 0.000592598071303
Prognostic Factor [clna] 0.000592331997238
Long [qlco] 0.000589866713518
Ii [aapp] 0.000585159218295
Risk factor [qnco] 0.000584832714349
Standard [qlco] 0.000580928601679
Altered [ftcn] 0.000580817802418
hormone replacement [topp] 0.0005804527866
Echocardiography [diap] 0.000580035254549
Lp(a) [aapp, bacs] 0.000579227906218
Pulse Pressure [orgf] 0.000577666219381
strategies [menp] 0.000577249745033
weight [orga] 0.000575070483059
Appropriate [qlco] 0.000575016441439
Coronary heart disease risk [inpr] 0.000574587521771
Systemic [ftcn] 0.000573939357726
High density lipoprotein [aapp, bacs, lipd] 0.000572194653755
Involved [ftcn] 0.000571407972861
H+ [elii] 0.000570846888977
Complex [qlco] 0.000568758384083
measurements [ftcn] 0.000565903289179
Hypothesis [idcn] 0.0005642717834
History [ocdi] 0.000563155048689
Coronary Disease [dsyn] 0.000560803130686
Contribute [acty] 0.000559653332237
Leading [tmco] 0.000559250799279
adverse effects [ftcn] 0.00055741673268
Relative [famg] 0.000556905375403
Male [fndg] 0.000555812524021
Intima media thickness [clna] 0.000552747112753
People [popg] 0.000551752844185
Action [ftcn] 0.000551426274951
Small [qnco] 0.000549864041275
reviewed [inpr] 0.000549402688615
prospective [resa] 0.000547847327171
Type [qlco] 0.000545649945923
Myocardial [spco] 0.000545577883801
Interaction [ftcn] 0.000545528399956
Diastolic blood pressure [clna] 0.000539141549675
???lead [elii, hops] 0.000538849213743
Modification [ftcn] 0.000538842340715
Class [inpr] 0.00053850351684
frequency [qnco] 0.000538171048677
Evaluation [ftcn] 0.000538097112895
mmol/L [qnco] 0.000537831274852
Recently [tmco] 0.000536758370262
Moderate [qlco] 0.00053649015101
Obese [dsyn] 0.000535610318387
Alternative [cnce] 0.000533269763272
Venous [bpoc] 0.000531971849456
Very [qlco] 0.000530642837121
Containing [ftcn] 0.000529796938638
Metabolic syndrome [dsyn] 0.000527847544396
Female [fndg] 0.000527536773217
Lipids [lipd] 0.000526027993266
Children [aggp] 0.000525869623212
Normotensive [fndg] 0.000524937483432
Ischaemic [ftcn] 0.000524658121619
Post-Menopause [orgf] 0.000524530313734
Link [inpr] 0.000524498021513
Screening [hlca] 0.000522935836836
Coagulation [ortf] 0.000521949131086
Medication [phsu] 0.000521705917764
Difficult [qlco] 0.000521557183963
Phase [tmco] 0.00052062725903
With [qlco] 0.000519001652152
Goal [inpr] 0.000516815077204
Measures [qnco] 0.000514534172929
Limited [ftcn] 0.000514363579525
heart rate [clna] 0.000512929243708
Literature [inpr] 0.000512868885867
Initiate [idcn] 0.000511275484273
Human [humn] 0.000508438196736
Issue [fndg] 0.000507281457062
Education [edac] 0.000507204145955
Concentration [menp] 0.000506990148164
Woman [popg] 0.000505639076792
Therapies [topp] 0.000504798977997
Hormone [horm] 0.000503268993304
Expression [topp] 0.000502259448347
Selective Estrogen Receptor Modulators [horm, phsu] 0.000502107131419
Method [inpr] 0.000501427391005
Lipoprotein (a) [aapp, bacs] 0.000500684798928
topic9
N NOS [aapp, imft] 0.00499253049806
Estrogen [horm, phsu, strd] 0.00495660258393
Men [popg] 0.00305402487232
Combined [qlco] 0.0029797441962
Subject [grup] 0.00285566119189
Receive [qlco] 0.0027594731343
Myocardial Infarction [dsyn] 0.00268330136367
Oral [spco] 0.00259857131053
Events [evnt] 0.00241884251667
mg% [qnco] 0.00234467554787
placebo [topp] 0.00229873454573
Osteoporosis [dsyn] 0.0022923111753
Old [tmco] 0.0022846975083
Change [ftcn] 0.00225874498407
Menopause [phsf] 0.00225041820458
Atherosclerosis [dsyn] 0.00223062993213
coronary [bpoc] 0.00219898312298
Decreased [qnco] 0.00212614360669
Early [tmco] 0.00210903780693
Lipid [lipd] 0.00209362938065
Breast Cancer [neop] 0.00207450039515
C-reactive protein [aapp, imft] 0.00198852443042
Blood Pressure [orgf] 0.00192320466512
Users [humn] 0.00191096365712
Raloxifene [orch, phsu] 0.00185930940173
Similar [qlco] 0.00182431953098
Estradiol [horm, phsu, strd] 0.00180227515855
Incidence [qnco] 0.0017615473642
Benefit [qnco] 0.0016813677274
Plasma [bdsu] 0.0016813136788
Science [ocdi] 0.00165733528076
Death [orgf] 0.00165229432484
Acute myocardial infarction [dsyn] 0.00165163655571
Measured [qlco] 0.0016515502382
randomized [resa] 0.00164757864518
Non [ftcn] 0.0016243679119
High Density Lipoprotein Cholesterol [bacs, lipd] 0.00162231469628
Progestin [horm, phsu, strd] 0.00158812290007
Stroke [dsyn] 0.00158762697442
development [phsf] 0.0015156220431
Confidence Interval [qnco] 0.00150078554849
function [phsf] 0.0014999044403
Common [qnco] 0.00149155667826
Drugs [phsu] 0.00147391793482
Profile [lbpr] 0.0014517889974
coronary artery disease [dsyn] 0.00145151928306
Drug Therapy [topp] 0.00143490376043
Diabetes [dsyn] 0.00142727976579
Assess [acty] 0.00140601611053
Known [qlco] 0.00139243758506
Induced [ftcn] 0.00138994037765
condition [dsyn] 0.00138820505682
weeks [tmco] 0.0013830873372
Large [qnco] 0.00138178229031
Recent [tmco] 0.00137223747199
Serum [bdsu] 0.00136779014801
Duration [tmco] 0.00136132335872
Received [qlco] 0.00136129310286
low [qlco] 0.00136103579595
Decrease [qlco] 0.00135753238847
mg dl [qnco] 0.00134270002471
Range [qnco] 0.00133253400361
Agent [chvf] 0.00133183335861
Values [qlco] 0.00132422205892
Likely [qlco] 0.00131856948713
Several [qnco] 0.00131256898311
Concentrations [menp] 0.00130130305952
Marker [clna] 0.00129493861819
Primary [qlco] 0.00129417629094
High Risk [qlco] 0.00129253809057
Benefits [qnco] 0.00126768032416
Statins [orch, phsu] 0.00126648624751
Body Mass Index [diap] 0.00126505573689
Combination [qlco] 0.00126288171895
Prevalence [qnco] 0.00125084859989
Estrogens [horm, phsu, strd] 0.00124292920318
Aspirin [orch, phsu] 0.00123821090238
considered [idcn] 0.001233055529
Take [hlca] 0.00123178491909
Following [tmco] 0.0012306029537
vascular [bpoc] 0.00122322402812
Total Cholesterol [lbpr] 0.00121740723658
mmHg [qnco] 0.00120110784497
APPEAR [qlco] 0.00119129836663
Secondary Prevention [topp] 0.00119122819627
Transdermal [ftcn] 0.00118617272399
Association [menp] 0.00118359028928
Available [ftcn] 0.00116653021557
Cholesterol, LDL [bacs, strd] 0.00116515353056
Predictor [idcn] 0.0011632316366
Individual [popg] 0.00116234890214
IMPACT [gngm] 0.00115663884026
Alone [qnco] 0.00115180018211
hypertensive [fndg] 0.00114702382989
Daily [tmco] 0.00114558851259
HRT [topp] 0.00114467216106
Article [inpr] 0.00114418835599
History [ocdi] 0.00114345981163
Specific [qlco] 0.00114246640314
Need [qlco] 0.00113915661608
Cholesterol [bacs, strd] 0.00113622110112
Cases [ftcn] 0.00112870968915
findings [ftcn] 0.0011280230099
Drug [phsu] 0.00111465120265
Provide [acty] 0.00110955032231
Improvement [cnce] 0.00110807276189
Guidelines [inpr] 0.00110742597362
Current [tmco] 0.00110669999919
PREVENT [phsu] 0.00110141819671
Aged [orga] 0.00109662432974
lowering [spco] 0.00109625772812
Overall [inpr] 0.00109014599523
Improved [qlco] 0.00108655465176
Smoking [inbe] 0.0010809892327
Care [acty] 0.00107225225244
progression [patf] 0.00106489986589
Published [ocac] 0.0010648933772
Administration [ocac] 0.00104851846491
Reported [inpr] 0.00103861551854
Endothelial [tisu] 0.00102998587404
Equal [qlco] 0.00102547145749
Main [qlco] 0.00102331656092
Response [orga] 0.00101684455593
diabetic [fndg] 0.00101340732907
Risk factor [qnco] 0.00101213559665
Exercise [dora] 0.00101126044579
Odds Ratio [qnco] 0.00100072022293
setting [ftcn] 0.000996690370327
Index [inpr] 0.000993191715614
median [spco] 0.000992599139036
Heart disease [dsyn] 0.000991327379178
Atrial Fibrillation [patf] 0.000990149256801
Safety [hcpp] 0.000989105900789
Evaluated [ftcn] 0.000988985145788
Therapeutic [topp] 0.000982996579627
I- [inch] 0.000981446696203
cardiovascular risk factor [dsyn] 0.000979807781029
Four [qnco] 0.000974291532583
Well [qlco] 0.000973514398503
Medical [ftcn] 0.000972704659107
Assessed [acty] 0.000972374674017
Triglycerides [bacs, lipd] 0.000972258729536
days [tmco] 0.000964878256694
Part [spco] 0.000963160192475
Statin [orch, phsu] 0.000959780918914
Surgery [bmod] 0.00095549603256
Elderly [popg] 0.000951402596972
month [tmco] 0.000951272620101
intervention [hlca] 0.000951119412515
activity [dora] 0.000947807138327
Average [qnco] 0.000947490577259
R- [spco] 0.000946257890678
Plus [qlco] 0.000945905901465
Independent [idcn] 0.000940491381939
cardiovascular events [fndg] 0.000937210075966
national [inpr] 0.00093565800235
practice [menp] 0.00092783350617
Recently [tmco] 0.000921086674135
Purpose [ftcn] 0.000917346402688
Additional [ftcn] 0.000912635492114
Various [irda] 0.000912292787759
Quality [qlco] 0.000911436967314
Continuous [idcn] 0.000910785857868
Diagnosis [fndg] 0.000910133738546
Make [ftcn] 0.000908880211051
symptoms [ftcn] 0.000904260093185
Approach [spco] 0.000892434445895
Null [qnco] 0.000892206194176
Myocardial [spco] 0.000891977212938
Heart [bpoc] 0.000891470442157
Hospital [hcro, mnob] 0.000881363715163
Concern [idcn] 0.000880507524603
Elevated [qlco] 0.000869786897074
Ireland [geoa] 0.00086940935326
radiotherapy [inpr] 0.000868836743443
Select [acty] 0.00086584789904
Morbidity [qnco] 0.000863917238943
Relative Risk [qnco] 0.000860121453685
Sclerotherapy [topp] 0.000855912557397
Risks [qlco] 0.000851605902076
Diabetes Mellitus [dsyn] 0.000850386315704
Report [inpr] 0.000848621847949
Assessment [hlca] 0.000845126756151
Dependent [qlco] 0.000844777984759
Primary Prevention [topp] 0.000840639465187
Ii [aapp] 0.000838904766655
Often [tmco] 0.000838420259465
Mechanisms [ftcn] 0.000838081163749
Possible [qlco] 0.000834588538674
Late [tmco] 0.00083333330319
Cost Effectiveness [qnco] 0.00083134341208
mediated [socb] 0.000829046014742
Information [idcn] 0.000828515723863
Replacement [topp] 0.00082831891606
Complications [patf] 0.000826030706425
LTD [ortf] 0.000825869043868
Obesity [dsyn] 0.000818537973587
Life [idcn] 0.000818473544112
Identified [qlco] 0.000818204273868
Dose [qnco] 0.000816473652131
Low density lipoprotein [aapp, bacs, lipd] 0.000816102654264
Initial [tmco] 0.000814330735852
Diet [food] 0.000808995611459
Young [tmco] 0.000807885171084
Currently [tmco] 0.000804920667515
Strong [qlco] 0.000804583893431
peripheral arterial disease [dsyn] 0.0008040580318
Same [qlco] 0.000803357226223
Low Density Lipoprotein Cholesterol [bacs, strd] 0.000797849714012
Comparison [acty] 0.000796459357044
Arterial [bpoc] 0.00079503589677
medroxyprogesterone acetate [horm, phsu, strd] 0.000793360520608
Flow [npop] 0.000791663504629
influential [idcn] 0.0007878643119
Evaluation [ftcn] 0.000787539912576
Recommended [idcn] 0.000784421447865
Obtained [ftcn] 0.000784012879463
participants [popg] 0.000783735900806
Reducing [qlco] 0.000782445514669
Life Style [socb] 0.000780795052326
Examined [fndg] 0.000778079759173
Affect [menp] 0.000773157769146
Clinical Trials [resa] 0.00077035243571
Future [tmco] 0.000767474011347
Equine [mamm] 0.000761964189883
Severity [qlco] 0.000760520834955
Adjusted [ftcn] 0.000758263304741
Long [qlco] 0.000757737280241
Needed [qlco] 0.000757455718359
Conduct [inbe] 0.000751028744645
Conjugated estrogen [horm, phsu, strd] 0.000750346369906
Value [qnco] 0.000747373811118
Insulin [aapp, horm, phsu] 0.000746190234029
Previous [tmco] 0.000745137218039
Dyslipidaemia [dsyn] 0.000741871187705
Six [qnco] 0.000741676409631
Addition [ftcn] 0.000737461351558
Estrogen Replacement Therapy [topp] 0.00073356329647
H+ [elii] 0.000732318649303
Cardiac [bpoc] 0.00073156778746
Direct [qlco] 0.00073071384661
Occur [acty] 0.000729659505248
Play [dora] 0.000729507344603
Normal [qlco] 0.00072943030973
Fibrinogen [aapp, bacs, phsu] 0.000726761681648
objectives [inpr] 0.000725613810403
mg day [qnco] 0.000724518998546
Lp(a) [aapp, bacs] 0.00071862529647
Established [qlco] 0.000715148819806
Increasing [ftcn] 0.000714314150623
Measure [qnco] 0.000714142785855
Lipoprotein (a) [aapp, bacs] 0.000713535805928
Echocardiography [diap] 0.00071231468167
Type [qlco] 0.000711657754582
acute [tmco] 0.000709279568231
investigate [ftcn] 0.000707569998934
Hypercholesterolaemia [dsyn] 0.00070434331459
Cohort [popg] 0.000701204530546
regimens [inpr] 0.000698365882084
Model [inpr] 0.000694014173779
Hormone [horm] 0.000693553220841
experience [menp] 0.000693432667562
Five [qnco] 0.00069168508818
Tamoxifen [orch, phsu] 0.000687694648245
Relationship [qlco] 0.000685692200883
Status [qlco] 0.000685017113057
Breast [bpoc] 0.000684291616822
Sex [orgf] 0.000678400982227
tibolone [phsu, strd] 0.000675765726906
Progesterone [horm, phsu, strd] 0.000674338134452
Support [medd] 0.000673686334851
Better [qlco] 0.000672248405967
Process [bpoc] 0.000671383383075
Compliance [qnco] 0.000664593639147
Heart failure [dsyn] 0.000663982509882
Very [qlco] 0.000663975263051
Natural [ftcn] 0.000662392814169
Cancer [neop] 0.000661370592766
Controlled [ftcn] 0.000655800349251
frequency [qnco] 0.000654407262055
prospective [resa] 0.000654293543205
Area [geoa] 0.000652060749945
variables [qlco] 0.000652057837353
Severe [qlco] 0.000650762280739
Presence [topp] 0.000650100982476
Medication [phsu] 0.000649123126001
In [qnco] 0.000648775426145
Selective Estrogen Receptor Modulators [horm, phsu] 0.000646614051868
Required [ftcn] 0.00064659138871
Systolic [tmco] 0.000646263990429
Literature [inpr] 0.000646028726461
Altered [ftcn] 0.000645290116192
matched [resa] 0.000644357809734
Ratio [qnco] 0.000642308255149
Single [popg] 0.000639662744312
Appropriate [qlco] 0.000638613473805
Lipids [lipd] 0.00063675369746
Coronary heart disease risk [inpr] 0.000634275121754
Question [inpr] 0.000632126080722
Target [ftcn] 0.000630982852635
Compare [acty] 0.000630093007559
Damage [inpo] 0.000628498988942
Cost [qnco] 0.000626606121271
ischaemic heart disease [dsyn] 0.000625811675409
Diastolic blood pressure [clna] 0.000622925332356
Venous [bpoc] 0.000621151942676
Progestagen [horm, phsu, strd] 0.000618135295585
Indicated [fndg] 0.000617216741226
Case [ftcn] 0.00061674948972
Estrogen Replacement [topp] 0.000613549410359
Treatments [topp] 0.000612199469671
recommendations [idcn] 0.000612068688872
Vascular Malformations [anab] 0.000611866957559
homocysteine [aapp, bacs] 0.000609550329372
Woman [popg] 0.00060541712278
Expression [topp] 0.000597280687773
Protection [fndg] 0.000596033708473
Interaction [ftcn] 0.000595046225779
Physical activity [dora] 0.000594813144487
hormone replacement [topp] 0.000593629605124
Cycle [tmco] 0.000591929826611
Menopausal [phsf] 0.000591620511089
interventions [hlca] 0.000587368668648
Frequently [tmco] 0.000586878763981
Triglyceride level [lbtr] 0.000586534680471
measurements [ftcn] 0.000586251729996
Effectiveness [qlco] 0.000584282314695
With [qlco] 0.000583987631609
Dietary [food] 0.000583672543934
Parameters [fndg] 0.000583274518188
Diseases [dsyn] 0.00058324416303
Physicians [prog] 0.00058322535665
Endothelium [tisu] 0.0005821151703
Assigned [ftcn] 0.000579124612812
Active [ftcn] 0.000579110463673
search [inpr] 0.000577426832982
side effects [ftcn] 0.000576821459163
atherosclerotic [ftcn] 0.000576400843143
mmol/L [qnco] 0.000574998481238
account [idcn] 0.000574214197029
If [qlco] 0.000573448097649
Seen [qlco] 0.000573143384791
Alternative [cnce] 0.000571076659355
Favorable [qlco] 0.000569036993263
Help [socb] 0.000568930089656
Administered [ftcn] 0.000567423646832
GH [aapp, enzy] 0.000566659737671
Characteristics [qlco] 0.00056620828543
Pravastatin [orch, phsu] 0.00056570867426
Now [tmco] 0.000564815299835
Relative [famg] 0.000559764516633
Out [spco] 0.000558581737979
Modification [ftcn] 0.000558471264941
weight [orga] 0.000554803648049
investigated [ftcn] 0.000553987494272
confirmed [qlco] 0.000549892046789
Standard [qlco] 0.000549841620517
High density lipoprotein [aapp, bacs, lipd] 0.000547360722932
Venous malformation [anab] 0.000545435477707
Female [fndg] 0.000544679812195
Percent [qnco] 0.000542434105775
Link [inpr] 0.000541738736992
Females [fndg] 0.000541005327954
Sample [sbst] 0.000533368111494
Frequent [tmco] 0.00053041225592
Post-Menopause [orgf] 0.000530071965544
adverse effects [ftcn] 0.000529881967826
admission [hlca] 0.000528784315693
Record [inpr] 0.000527826193299
Velocity [qnco] 0.000527298251523
Occurred [acty] 0.000524098953373
Screening [hlca] 0.000521583677839
Metabolic [ftcn] 0.000519454985545
TREAT [ftcn] 0.000518663827859
Last [qlco] 0.000518106500407
Few [qnco] 0.00051792173583
Survival [acty] 0.000516866271344
Observational Study [resa] 0.000516032346415
Prognostic Factor [clna] 0.000514699882112
Defined [cnce] 0.000514417590373
High density lipoprotein cholesterol level [lbpr] 0.000513810113505
Involved [ftcn] 0.000510369110024
Documented [hlca] 0.000509862709509
Angina, Unstable [dsyn] 0.000509123641822
American [popg] 0.000507819709177
Adjustment [inbe] 0.000506410442011
Class [inpr] 0.000504704633299
premenopausal [tmco] 0.000504443291453
Mechanism [ftcn] 0.000503032741713
reductions [npop] 0.000502982861458
Complex [qlco] 0.000501006012806
Multiple [qnco] 0.000500756446643
DOUBLE BLIND [resa] 0.000498996437653
Correlation [qlco] 0.000498694936618
properties [qlco] 0.000498364741287
Male [fndg] 0.000497551452363
Metabolic syndrome [dsyn] 0.000495304801225
Intima media thickness [clna] 0.000494297178107
Thrombolytic Therapy [topp] 0.000493710782192
Glucose [bacs, carb, phsu] 0.000491667884831
